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ABSTRACT OF THE THESIS 
 
The Effect of Grapes in Mice with Alzheimer’s Disease and Brain Injury 
 
by 
Nikita Mistry 
Doctor of Philosophy, Graduate Program in Experimental Psychology 
Loma Linda University, December 2014 
Richard E. Hartman, Chairperson 
 
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder resulting in 
cognitive and memory deficits and deposits of amyloid beta (Aβ) in the cortex and 
hippocampus are thought to be significant contributors to the disease process. Increasing 
evidence suggests that foods rich in polyphenols, such as pomegranates and grapes, may 
have neuroprotective effects in both rodents and humans. Our previous research has 
shown that a pomegranate-enriched diet decreased Aβ plaque load and improved 
behavior in Tg2576 mice. In this study, we determined whether a grape-enriched diet 
altered Aβ neuropathology and TBI in PSAPP mice. Mice received either craniotomy or a 
moderate TBI. Naïve mice (non-injured) underwent anesthesia. Mice consumed either a 
grape-enriched or a control diet for 8 weeks. Behavioral tests were administered 2 weeks 
after injury. CCI mice showed significant motor and memory deficits, with no effect of 
diet. The grape-enriched diet trended towards the reduction of lesion volume and motor 
deficits in craniotomy mice. Most surprising, CCI reduced fibrillar Aβ plaque load while 
diet did not have an affect on AD neuropathology. These results suggest that brain injury 
may be neuroprotective against the progression of AD.  
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CHAPTER ONE 
INTRODUCTION 
 Alzheimer’s disease (AD) is the most common neurodegenerative disease and can 
cause brain atrophy and behavioral deficits. AD neuropathology usually begins in the 
temporal lobes, leading to the first signs of memory and emotional problems and 
eventually progresses to the frontal and parietal lobes, further contributing to personality 
changes, language difficulties, impaired decision-making and motor impairment.  
Neuropathology consists of the aggregation of misfolded proteins in the brain’s 
extracellular space (plaques of amyloid beta [Aβ]) and within neuronal axons and 
dendrites (neurofibrillary tangles [NFTs] of tau protein). The Aβ plaques disrupt neuronal 
signaling (Uryu et al., 2002), causing the breakdown of necessary communication of 
networks in the brain. Aβ deposition generally begins in the temporal lobe within and 
around the entorhinal cortex and the hippocampal formation, which impacts learning and 
memory, then spreads to the cortical and subcortical areas that impact language, 
executive, and motor functions. The phosphorylation (addition of a phosphate group) of 
the tau protein regulates its activity to bind to microtubules and stimulates the assembly 
and the maintenance of the axonal structure. In AD, tau is hyperphosphorylated (too 
many phosphate groups attach) and this causes tau to lose its normal biological activity. 
Tau proteins aggregate and form tangles (NFTs) within the axon, eventually collapsing 
the axonal structure and transport mechanisms (Wakasaya et al, 2011). Tau proteins 
aggregate and form tangles (NFTs) within the axon. Both Aβ and NFTs are associated 
with increased oxidative stress, inflammation, glial activation, synaptic loss, apoptosis 
(cellular suicide), mitochondrial dysfunction, and vascular plaque deposition in the brain.  
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Several risk factors for the disease include aging, genetic mutations, diet, and 
brain injury. Genes associated with early-onset / familial AD (FAD) contributes to only 
10% of AD cases. FAD symptoms typically develop during the 50s, and sometimes as 
early as 30 years of age. Behavioral and neurological assessments are commonly used to 
diagnose AD, however, other neurological diseases may present similar symptoms. 
Unfortunately, typical behavioral symptoms are not observed until significant levels of 
neurodegeneration have occurred. Because this process may take decades, a concrete 
diagnosis of AD can only be confirmed after post-mortem neuropathological analysis.  
 
Amyloid Precursor Protein Gene Family 
 Mutations of presenilin 1 (PSEN1), presenilin 2 (PSEN2), and/or APP can 
enhance cleavage patterns in support of Aβ (Karran, Mercken, & De Strooper, 2011). The 
human APP gene is located on chromosome 21 and is expressed in many tissues and 
organs, including the brain and spinal cord. It encodes amyloid precursor protein (APP), 
which is a protein partially embedded in the cell membrane with a large extracellular 
domain, and mutations in APP are thought to play a significant role AD pathology. More 
than 25 APP mutations have been identified that cause FAD and the deposition of Aβ in 
the brain’s blood vessels (cerebral amyloid angiopathy; CAA). These mutations alter the 
genetic code and will ultimately lead to the production of abnormal APP that has affinity 
for aggregation. Approximately 10 percent of these mutations are responsible for FAD. In 
CAA, blood flow becomes more constricted due to the buildup of amyloid proteins inside 
vasculature, leading to cerebral microbleeds (Carrano et al., 2011). This increases the risk 
of stroke, oxidative damage and blood brain barrier dysfunction drastically. Because this 
mutation is found in approximately ¼ of adults with AD, CAA mouse models (e.g., the 
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SAMP8 mouse) have been developed to better define the similarities between the 
diseases. Briefly, this model mimics the altered phospholipid content in cell membranes 
and early abnormalities in learning and memory that are characteristic in AD (Morley, 
2003). 
 Presenilins are a family of transmembrane proteins that function in the processing 
and trafficking of membrane-bound proteins in neurons. Mutations in PSEN1 and PSEN2 
have been identified in the majority of early-onset autosomal AD. Presenilins 1 & 2 is 
thought to regulate the cleavage activities of many proteins in the cell, including gamma 
secretase (Hutton & Hardy, 1997; Sherrington et al., 1995). These mutations disrupt 
normal APP processing, leading to the overproduction of A (Sherrington et al., 1996). 
Some research suggests that blocking γ-secretase may decrease Aβ induced oxidative 
stress by increasing mitochondrial function (Sheng et al., 2009; Kurz et al., 2010) and 
promote normal cellular activity and viability.  However, these drugs have adverse side 
effects. Blocking gamma secretase also leads to the inhibition of other crucial cellular 
processes and may cause abnormalities and cytotoxicity in the gastrointestinal tract, 
thymus, and spleen in rodents (Imbimbo, 2008).  
 Despite the large number of published studies on APP, there is still no clear 
consensus on the protein’s function. A recent review by Dawkins and Small (2014) 
summarizes the major ideas relating to the function of the protein, suggesting that normal 
APP interacts both intracellularly and extracellularly to regulate various signal 
transduction mechanisms. More specifically, the physiological role of APP may involve 
neural stem cell development, neuronal survival, neurite outgrowth, and neurorepair. 
Evidence also suggests that APP may play an important role in synapse formation, neural 
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plasticity, and axonal transport. APP accumulates in presynaptic terminals and growth 
cones and may function to inhibit synapse formation. In mouse models where APP is 
genetically removed (APP-/-), a number of deficits are associated with altered synaptic 
function in hippocampal neurons, such as hypersensitivity to kainate-induced seizures, 
alterations in dendritic spine density, and reduced performance in tests of spatial memory 
(Steinbach et al. 1998; Dawson et al. 1999).  
 APP is delivered to the surface of cell membranes where it is metabolized into a 
number of protein fragments by the alpha- (α), beta- (β), and gamma- (γ) secretases, 
yielding a variety of amino- (N-) terminal (free floating) and membrane anchored 
carboxy- (C-) protein fragments. APP that fails to be cleaved by α-secretase can be 
internalized into endocytotic compartments (engulfed) and subsequently cleaved to 
generate A (Kamenetz et al., 2003). In general, APP cleavage tends to follow one of two 
pathways: the amyloidogenic pathway (producing the A peptide) and the non-
amyloidogenic pathway (preventing production of the A peptide; Karran, Mercken, & 
De Strooper, 2011). 
 
Amyloid Beta Production 
Amyloid beta peptides (39-43 amino acids each) are formed from APP by specific 
enzymatic cleavage sequences into smaller protein fragments (peptides). In a healthy 
brain, these protein fragments are broken down and eliminated. In an AD brain, A 
fragments gradually accumulate and trigger downstream events causing functional 
neuronal deficits, oxidative stress (OS), and cell death. The amyloid cascade hypothesis 
(Figure 1) suggests that mutations enhance the formation of soluble toxic A oligomers 
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and/or deposited fibrillar amyloid peptides. With the development of A aggregates, OS 
levels in the brain are amplified, leading to cellular degeneration, followed by increased 
production of APP and its subsequent cleavage via the amyloidogenic pathway. As a 
result, the cycle continues to generate A, which aggregates into plaques, causing the 
development of NFTs, ultimately leading to severe neuronal degeneration.  
 
 
 
Figure 1. The amyloid cascade hypothesis. Genetic and spontaneous mutations of APP 
lead to A aggregation and stress, eventually leading to NFTs and further degeneration.  
 
 
 
The Amyloidogenic Pathway 
 APP is first cleaved by β-secretase near the membrane surface followed by γ-
secretase to yield Aβ monomers. The initial cleavage of APP by β-secretase yields a 
soluble N-terminal (sAPPβ) fragment and membrane bound C-terminal end (CTFβ). 
Next, the cleavage of the membrane bound CTFβ fragment by γ-secretase yields two 
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more fragments: Aβ and CTFγ, a membrane bound APP intracellular domain (AICD). 
The specific cleavage site of γ-secretase may result in different peptide sequences ranging 
from 39 to 43 amino acids. Amyloid beta sequences of 40 (Aβ40) and 42 (Aβ42) are 
commonly found in AD, with Aβ42 more likely to aggregate into β-pleated sheets, 
compared to shorter soluble isoforms. Aβ40 remains in a less toxic monomeric peptide 
sequence. With large enough concentrations of these monomers begin to aggregate to 
form large diffuse Aβ fragments called oligomers. Strands of Aβ42 also tend to cluster 
together and form oligomeric aggregates that become tangled with neighboring cells and 
synapses. As more oligomers cluster together, the structure undergoes conformational 
changes, leading to the formation of amyloid β-sheets (Askarova, Yang & Lee, 2011). 
The stacking of these sheets are called fibrillar amyloid β-sheets, are extremely dense and 
resistant to degradation (Askarova, Yang & Lee, 2011).   The deposition of these fibrillar, 
more end stage AD plaques are associated with oxidative stress, disrupting neuronal 
signaling, and contributing to neuritic degeneration (Han et al., 2006; Jacobsen et al., 
2006).  
 
The Non-Amyloidogenic Pathway 
 APP is cleaved by α-secretase followed by γ-secretase to yield a non-toxic 
protein. Cleavage by α-secretase yields a soluble N-terminal (sAPPα) fragment and a 
membrane bound C-terminal end (CTFα). This results in larger sAPPα chains that reduce 
the chances of the formation of Aβ monomer fragments. Also, sAPPa may be involved in 
the formation of synapses, neurite outgrowth and neuronal survival, and are considered to 
be neuroprotective (Chasseigneaux & Allinquant, 2012). Finally, γ-secretase cleaves 
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CTFα to yield a soluble p3 fragment and a membrane bound AICD fragment (Askarova, 
Yang & Lee, 2011). Because the full-length Aβ protein is not produced, these cleavage 
sites release fragments that may contribute to neuronal survival.  
 
Oxidative Stress 
 Oxidative stress (OS) occurs from the imbalance in the normal reactive state of 
tissues that can cause toxic effects through the production of peroxides and free oxygen 
radicals, which in turn damage cellular components including proteins, lipids and 
deoxyribonucleic acid (DNA). Although, OS increases with age, brain injuries and/or 
neurological diseases exacerbate its concentration and causes more harm in the brain. 
Research in AD has recently demonstrated compelling evidence on the importance of 
oxidative processes and pathology. Several studies have identified the roles oxidative 
stress, free radical damage, and inflammation has in pathology and possibility the 
etiology of AD. Oxidative species and free radicals may initially be products of 
mitochondrial dysfunction and imbalances of trace elements such as iron and copper 
(Perry, Cash, & Smith, 2002). These metals generate reactive oxygen species that 
ultimately disrupt metabolic cellular processes (Honda, Casadesus, Peterson, Perry, & 
Smith, 2004). Increased oxidative species may trigger cytoskeletal modifications in 
susceptible neurons (leading to NFTs) (Honda et al., 2004; Perry et al., 2002) and the up-
regulation of presenilin 1 to produce Aβ (Oda, Tamaoka & Araki, 2010), consequently 
leading to the development of AD. Aβ induced toxicity continues to disrupt of neural 
networks and affects long-term potentiation and memory consolidation, eventually 
leading to cognitive deficits (Jacobsen et al., 2006).  
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Brain injury induces inflammation and toxicity with increased free radical 
production in the brain. With each additional injury, the cytotoxic environment continues 
to rise, eventually leading to neurodegenerative diseases. For example, traumatic brain 
injury accelerates the formation of Aβ deposits (Uryu et al., 2002), damages hippocampal 
neurons, and induces learning and memory behavioral deficits (Han & Chung, 2006). 
This is especially evident in athletes such as boxers and football players that will present 
cognitive symptoms and plaque pathology similar to AD and other dementias (Mitsis et 
al., 2014; Jordan, 2000). These types of repetitive concussive injuries can further 
accelerate OS levels and chronic inflammatory responses, leading to continued tissue 
degeneration.  
 
Mouse Models in Alzheimer’s Disease 
 Many neurological diseases are difficult to study using human models because of 
the significant risks, time, and ethical issues involved in experimental studies. As a result, 
many researchers use animal models to investigate disease pathologies, therapies, and 
cures. Transgenic mice with Alzheimer’s-like pathology have been developed in an 
attempt to understand the disease in its entirety at a faster pace. These mice develop the 
pathological (Hsiao et al., 1996; Jacobsen et al., 2006; McGowen et al., 1999) and 
behavioral hallmarks (Liu, et al., 2008) of AD similar to those seen in adults. Commonly 
used mouse models are described below.  
 The first transgenic mouse created was the PDAPP model. These mice express a 
double APP mutation associated with autosomal dominant forms of human AD. Plaque 
deposition occurs at approximately at 6 months in the cortex, followed by progression to 
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the hippocampus and corpus callosum. These mice have a 5 to 10 fold increase in Aβ 
production compared to controls and noticeable learning and memory impairments before 
the plaque deposition. Behavioral deficits and hippocampal volume reductions 
characteristic in this model are similar to those found in human AD patients (Games et 
al., 1995).    
 The Tg2576 (APP695SWE) mice model is used to study the early-onset of AD. 
These mice express a human APP from a Swedish family, which results in a double 
mutation in APP695 (Lysine
670  Asparagine, Methionine671  Leucine). These mice 
have 5 times more soluble Aβ and 14 times the toxic Aβ plaques compared to humans 
(Hsiao et al., 1996). Plaque deposition begins in the entorhinal and piriform cortices, 
thereafter proceeding to the cingulate and motor cortices (McGowen et al., 1999), with 
learning and memory impairments are observed by 9 months (Hsiao et al., 1996).   
 A multi-gene transgenic mouse model PSAPP is also used to study the early-onset 
of AD. This model involves the crossing of the human PSEN1 mutation with Tg2576 
mice. Behavioral deficits are detectable beginning around 6 to 7 months. Differing from 
Tg2576 mice, plaque deposition in these mice begins around 5 months in the cingulate 
and motor cortices, thereafter proceeding to the entorhinal and piriform cortices 
(McGowen et al., 1999).  
 A triple transgenic mouse model (3xTg-AD) has been newly developed study AD. 
This model aims to mimic the neuropathology of the disease in humans very closely. 
Mice harbor 3 mutant transgenes: human PS1M146V, double mutation APPSWE, and human 
tauP01L. Mice develop progressive and age-dependent A and tau pathology, with A 
deposition around 6 months followed by tau aggregates at 12 months. The A deposits 
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being in the cortex, then spreads to the hippocampus with age. In comparison, tau 
pathology begins in the hippocampus and progresses to the cortex (Oddo, Caccamo, 
Kitazawa, Tseng & LaFerla, 2003).   
 
Risk Factors in Alzheimer’s Disease 
Genetics 
 Autosomal mutations in genes that encode APP and presenilins predispose 
individuals to develop early-onset FAD by either by increased levels of APP in the brain 
or accelerating processing of APP to form Aβ. A major genetic risk factor for the more 
common late-onset AD is carrying a copy of the ɛ4 allele of the gene that encodes 
apolipoprotein E (APOE). APOE is a low-density lipoprotein that typically functions in 
the movement of lipoproteins, fat-soluble molecules, and cholesterol within the 
bloodstream and seems to play an important role in AD pathogenesis. APOE is primarily 
produced by astrocytes, microglia, and may interact a number of receptors as well as 
structures in the brain.  
There are multiple isoforms of the APOE gene: ɛ2, ɛ3, AND ɛ4. Those with the 
APOE4 gene are more likely to develop AD and two copies of the gene may accelerate 
Aβ processing and increase plaque burden and toxicity (Askarova, Yang & Lee, 2011), 
thus presenting a higher risk for developing the disease. Carriers of the ɛ4 allele have 
early signs of degeneration in the brain such as reduced cortical thickness in the 
entorhinal cortex and subiculum (Burggren et al., 2008), age related reduction in 
hippocampal volume (Jak, Houston, Nagel, Corey-Bloom, & Bondi, 2007; Lind et al., 
2006), and impaired performance on cognitive learning and memory tasks (Lind et al., 
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2006). Research has shown that mice deficient in APOE (-/-) do not express astrocytes 
around the blood brain barrier, leaving the brain more vulnerable to injury and 
subsequent damages (Methia et al., 2001). This causes transport mechanisms to be lost 
and/or allows other endogenous substances to enter the brain. As such, APOE plays a 
critical role in the maintenance of brain health.  
Copies of ɛ2 and ɛ3 alleles are known to be protective against AD. The ɛ3 allele is 
a neutral and asymptomatic to any known diseases. Although the ɛ2 allele does not play a 
role in AD, it is involved in lipid and cholesterol transport and dysfunction that may 
increase the risk for cardiovascular diseases (Civeira et al., 1996).  
 
Diet 
 Evidence suggests that diets can have serious implications in altering the 
physiological functions of the brain and increasing the risk of psychiatric and 
neurological disorders. For example, high fat diets promote vascular atherosclerosis 
(Franciosi et al., 2009; Lemieux et al, 2010) and behavioral deficits (Li, Cao, Garber, 
Kim & Fukuchi, 2003; Liu et al., 2008) by altered cholesterol and phospholipid levels in 
cell membranes. These changes can modulate activity of membrane bound enzymes 
including β- and γ-secretases that enhance Aβ production in the brain significantly. High-
cholesterol diets have been shown to increase Aβ pathology in the brains of rabbits 
(Lemieux et al, 2010; Ronald et al., 2009; Wu et al., 2003) and APP transgenic mice 
(Hooijmans et al., 2007; Pedrini et al., 2009; Shie, Jin, Cook, Leverenz & LeBoeuf, 
2002). Specifically, high intake up-regulates APOE, which in turn up-regulates Aβ 
plaque deposition in rabbits (Wu et al., 2003). High fat diets also increase tau pathology 
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(Glöckner, Meske, Lütjohann & Ohm, 2011) and astrogliosis (Crisby, Rahman, Winblad 
& Schultzberg, 2004) in APOE (-/-) deficient mice.  
 
Traumatic Brain Injury 
 Traumatic brain injuries (TBI), such as those commonly caused from falls, 
contact sports, vehicular accidents, violence, and military combat may lead to long-
lasting cognitive and motor deficits, and increase the risk of developing future 
neurological disorders. An estimated 1.7 million people are affected by TBI annually and 
is the leading cause of death and disability in both combat and civilian circumstances 
(Yu, Watt, & Mohan, 2013). TBI affects all ages and socioeconomic classes and may 
result in short-term and/or long-term motor, cognitive, and emotional deficits (Budinich, 
Tucker, Lowe, Rosenberger, & McCabe, 2013). Despite the high incidence of TBI, few 
preventative and treatment options are available (Chauhan, Gatto, & Chauhan, 2010).  
Sources of TBI include any external mechanical force, penetration by an object, 
and direct or indirect impacts. TBI may be classified based on severity (e.g. mild, 
moderate, or severe), injury location, time of lost consciousness, with symptoms lasting 
from seconds to possibly years. Recoveries of motor and cognitive deficits are dependent 
on the severity of the injury (Huh et al., 2011). Physiological responses to brain injury 
include increased OS, excitotoxicity, mitochondrial dysfunction, inflammation, cellular 
dystrophy, and other processes that will ultimately result in neuronal death. The initial 
impact results in the displacement of the structures in the brain. This includes contusion, 
damage to the blood vessels, axonal shearing, and compromised blood brain barrier 
(BBB) and meninges. Secondary injuries occur in the hours and days following the 
 13 
primary injury, where the brain’s activated metabolic networks remain heightened and 
continue to inflict damage over time. Secondary injuries include but are not limited to 
insufficient blood and oxygen flow to the brain and cranial swelling often cause the 
persistent long-term deficits.  
 Mild to moderate TBI leads to impairments in executive processing, long-term 
memory consolidation (Miotto et al., 2010), strategy and decision-making (Miotto et al., 
2010; Noordt & Good, 2011), episodic memory, and in verbal recognition and verbal 
episodic memory tasks (Miotto et al., 2010). Severe TBI leads to cognitive and motor 
deficits that are more damaging and long lasting, resulting from widespread tissue 
degeneration. These occur as a result from sustained cerebral contusions, diffuse axonal 
injury, ischemic brain damage, symmetrical ventricular enlargement, and an increase in 
intracranial pressure (Adams et al., 2011).  
 Experimental models of TBI have been developed to mimic physiological and 
behavioral deficits found in humans. Controlled cortical impact (CCI) is commonly used 
as a rodent model of TBI that allows independent control of many mechanical parameters 
and produces many of the features found in TBI (Dixon, 2009). A piston is used to 
directly impact the cortex and will result in a variety of acute and long-term behavioral 
impairments. This model is essential in delivering a focal, more specific TBI due to the 
fact that severity can be manipulated by varying the piston’s speed and/or depth, with 
larger depth and speed inducing larger locomotor and cognitive deficits.   
Diffuse axonal injures are more widespread and occur regardless of severity 
(Adams et al., 2011). These are characterized by extensive lesions in the white matter 
tracts that disrupt nerve impulses throughout the brain, resulting in cognitive impairment 
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(Kinnunen et al., 2011). Unfortunately, the risk of experiencing more tissue damage and 
behavioral deficits increases with each repeated TBI. Individuals who have experienced 
one brain injury are three times as more likely to experience a second brain injury 
(DeFord SM, Wilson MS, Rice AC, Clausen T, Rice LK, Barabnova A, et al). A recent 
study assessed the temporal development of neuropathology in a CCI rat model. This 
study used MRI techniques to investigate the effects of repeated mild TBI (1 impact to 
each cortical hemisphere (Donovan 2012)). Tissue damage was exacerbated following 
the second mild TBI, most notably when injuries were seven days apart (Donovan 2012). 
The repetitive nature of these injuries accelerated neuronal damage, oxidative stress, 
(Han et al., 2006) and cognitive impairments (Uryu, et al., 2002). Strikingly, these 
cortical white matter abnormalities are observed as late as 60 days post injury (Donovan 
2014). These studies suggest that the brain remains vulnerable to a subsequent injury for 
a period of time, increasing the probability of additional tissue damage and behavioral 
deficits (Yu S, Kaneko Y, Bae E, Stahl CE, Wang Y, van Loveren H, et al).  
TBI produces behavioral deficits (Creed, DiLeonardi, Fox, Tessler, & 
Raghupathi, 2011) and cellular pathology (Alder, Fujioka, Lifshitz, Corckett, & Thakker-
Varia, 2011; Huh, Widing, & Raghupathi, 2011; Li, Li, Feng, & Gu, 2011) similar to 
adults with AD. Athletes such as football players and boxers are at an increased risk for 
developing early onset AD with each repetitive TBI. Interestingly, individuals with TBI 
have shown evidence of extensive cortical A plaque deposition (Roberts et al., 1994). 
Aβ plaques also form immediately post injury in the cortex (Gentleman et al., 1997; Valle 
et al., 2011) and continue to form several weeks after (Uryu et al., 2002) as a result of the 
heightened expression of APP (Tatsuki et al., 2009).  Increased concentrations of soluble 
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A42 in the cortex (DeKosky et al., 2007) and cerebral spinal fluid (Olsson et al., 2004) 
have also been recorded. It is this gradual accumulation of A that causes 
pathophysiological changes in the brain that generally increases the risk of developing 
AD neuropathology. Unfortunately, few pharmacological treatments are available for 
TBI and those that are available have significant adverse side effects. These treatments 
are typically implemented after the injury has occurred and may be too late in preventing 
further neurodegeneration. Consequently, TBI may predispose individuals to develop 
neurodegenerative diseases such as Alzheimer’s disease, earlier than the normal aging 
population. 
   
The Blood Brain Barrier 
 The neurovascular unit is a complex network of neurons, vascular cells 
(endothelia, pericytes, smooth muscle cells), and glia (astrocytes, microglia, and 
oligodendroglia). The vascular cells and glia form the anatomical, biochemical, and 
barrier systems of the central nervous system. The blood brain barrier (BBB) is composed 
of endothelial cells that are surrounded by basement membranes, pericytes, and astrocytic 
endfeet. These characteristics in addition to tight junctions support the integrity of the 
BBB. There is growing evidence that brain injury, whether its ischemic, hemorrhagic, or 
traumatic leads to dysfunction of BBB. Changes in the permeability of the BBB are 
observed after injury and are thought to contribute to the degeneration of tissue in the 
brain. For example, failed clearance mechanisms of the BBB lead to Aβ plaque 
deposition in the brain, opening the route to further neuronal degradation.  
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Receptor for Advanced Glycation End Products 
The human receptor for advanced endproducts (RAGE) is a multiligand cell 
surface protein that is involved in inflammatory and immune responses. Rage is 
expressed by a number of cell types including neurons, microglia, astrocytes, and 
endothelial cells in the central nervous system. RAGE is a receptor for multiple proteins 
including Aβ. RAGE that is expressed in the surface capillaries of endothelial cells in the 
BBB regulate the influx of peripheral Aβ into the brain (Mackic et al., 1998). The 
inflammatory response triggered from AD (Lue et al., 2001), leads to higher OS levels 
and increased Aβ transport across the BBB (Deane et al., 2006). Transportation further 
signals the up-regulation of RAGE dramatically, leading to higher concentrations of the 
receptor and Aβ in the hippocampus (Donahue et al., 2006) and Aβ in blood capillaries 
(Jaynes & Provias, 2008), ultimately leading to neuronal loss. Since Aβ mediation by 
RAGE contributes to neuronal dysfunction, blocking the receptor may ameliorate cellular 
toxicity and reduce Aβ levels (Carrano et al., 2011), thus slowing the progression of AD.  
 
Astrocytic Activation 
 Astrocytes are star-shaped glial cells located in the brain and spinal cord that are 
critical to the maintenance and functioning of the brain. These cells envelope synapses 
between neurons, surround endothelial cells in the BBB, play a role in repair and scarring 
from injury, and control the extracellular space and its contents in the brain. Astrocytes 
become activated (reactive) in response to inflammation or to CNS pathologies, such as 
stroke, traumatic brain injury, and AD. Reactive astrogliosis occurs when the astrocytes 
surround a lesioned area of interest and undergo morphological changes that include 
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hypertrophy, branching of processes, and proliferation (Perez, et al., 2010; Rodríguez, 
Olabarria, Chvatal, & Verkhratsky, 2009) in an attempt to isolate the area and prevent 
further cellular degradation. Thereafter, astrocytes replace the damaged tissue with a glial 
scar (Rodríguez et al., 2009) to contain the damaged area. 
In neurodegenerative diseases such as AD, astrogliosis begins several months 
prior to Aβ plaque deposition in APP transgenic mice (Heneka et al., 2005; Mei, 
Ezan,Giaume, & Koulakoff, 2010) and continues to increase as the disease advances. 
Activated astrocytes surround and become intertwined with Aβ plaques (Rodríguez et al, 
2009) and attempt to separate them from nearby neurons (Wegiel et al., 2000). In a study 
where non-transgenic rats were injected with Aβ1-42 oligomers, significant activated 
astrocytes were found around the injection site compared to control Aβ42-1 animals 
(reversed peptide without fibrillogenic properties) (Perez et al., 2010). Astrocytes also 
surround and ingest more diffuse oligomeric Aβ than fibrillar Aβ (Nielsen et al., 2010), 
suggesting its role to minimize damage triggered from AD.  
 
Polyphenolic Compounds 
 Many studies suggest that diets high in antioxidants and polyphenols attenuate 
neuronal degradation. Polyphenols are water soluble, organic chemicals that are high in 
antioxidant and anti-inflammatory properties. Commonly found in a wide range of fruit 
and spices, the supplementation of these compounds into diets may be an advantageous 
method to slowing neurological diseases, compared to moderately effective 
pharmaceutical medications.  
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 Epidemiological studies suggest the role of polyphenolic compounds in 
attenuating age-related deficits, with recent attention directed towards a well balanced, 
high polyphenol diet. The Mediterranean diet is simplistic and typically abundant in fresh 
fruits, vegetables, breads, beans, nuts, seeds, olive oil, cheese, yogurt, seafood, and wine. 
High adherence to the Mediterranean diet is associated with lower cognitive decline 
(Féart, Samieri, & Bargerger-Gateau, 2010; Féart, Pérès, Samieri, Letenneur, Dartigues 
& Bargerger-Gateau, 2011; Scarmeas, Stern, Mayeux, Manly, Schupf & Luchsinger, 
2009), risk of developing AD (Arab & Sabbagh, 2010; Gu, Luchsinger, Stern & 
Scarmeas, 2010; Scarmeas, Luchsinger, Schupf, Brickman, Cosentino, Tang & Stern, 
2009), and mortality from AD (Scarmeas, Luchsinger, Mayeux & Stern, 2007).  
 
Curcumin, Ginko Biloba, and Caffeine 
Several spices and teas that are typically found in eastern diets are high in anti-
inflammatory properties that exhibit neuroprotection against OS induced damage and 
attenuate neuronal degradation. In AD cell culture and mouse models, treatment with 
curcumin (turmeric) resulted in a reduction of A 40 and A 42 peptide levels (Zhang, 
Browne, Child & Tanzi, 2010) and protection against DNA damage (Thomas et al., 
2009). Ginko biloba extract reduced inflammation (Boghdady, 2013), thereby up-
regulating mitochondrial DNA and reducing Aβ oxidation (Rhein et al., 2010). The 
polyphenols found in green tea may also improve mitochondrial function (Chen, Lin, Liu 
& Lin-Shiau, 2008), delay neuronal damage (Park et al., 2009), reduce glial swelling 
(Panickar, Polansky & Anderson, 2009), and reduce oxidative damage (Etus, Altug, 
Belce & Ceylan, 2003). Caffeine may also provide neuroprotection against 
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neurodegenerative diseases as well. Acute administration of caffeine before brain injury 
significantly reduced Aβ plasma levels in both young and old AD (APPSW) mice (Cao et 
al., 2009).  More specifically, higher levels of caffeine in plasma were associated with 
lower Aβ plasma levels (Cao et al., 2009).  
 
Vitamins C and E 
Vitamin C and E are naturally occurring antioxidants that also have been shown 
to improve cognitive deficits and ameliorate AD pathology. In fact, supplementation of 
vitamins may improve cognitive outcomes in adults with AD, who typically have lower 
plasma levels of vitamins C and E (Riviere, Birlouez-Aragon, Nourshashemi & Vellas, 
1998). In an AD mouse model (APP/PS1), both middle aged and older mice injected with 
vitamin C one hour prior to behavioral testing showed improvement in spatial learning 
and memory tasks (Harrison, Hossenini, McDonald & May, 2009). Treatment with 
vitamin E may also reduce amyloid deposition and behavioral deficits. In another AD 
mouse model (Tg2576), 11-month-old female mice were given vitamin E four weeks 
prior to repetitive concussive brain injury, and continued with the supplemented 
treatment up to eight weeks post-injury (Conte et al., 2004). Injured mice on the 
supplemented treatment improved in learning and memory tasks and also had reduced 
amyloid deposition both in the hippocampus and cortex (Conte et al., 2004). 
 
Berries 
A variety of different berries have also been found to protect against inflammation 
and neuronal damage caused by AD. In a CO7 cell culture model, blueberries protected 
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against toxicity from A, leading to better cell viability (Joseph, Fisher & Carey, 2004). 
Similarly, treating primary mouse cultured microglia with blueberries reduced 
inflammation and microglial activation (Zhu, Bickford, Sanberg, Giunta & Tan, 2008). 
Blueberry supplementation (2% concentration) for 4 months also lowered oxidative stress 
induced inflammation in older mice (Goyarzu et al., 2004). In addition, AD mice 
(APP/PS1) given blueberry in rodent chow (2% concentration of blueberry extract milled 
into pellets) given for 8 months, showed significant improvement in behavior and trended 
towards lower A plaque burden in cortical tissue (Joseph et al., 2003). Similarly, diets 
supplemented with blackberries and strawberries also improved age-related deficits in 
normal aging rats (Joseph et al., 1998; Shukitt-Hale, Cheng & Joseph, 2009).  
 
Pomegranate Juice 
Pomegranates are naturally high in polyphenolic properties and have been shown 
to have antioxidant, anti-inflammatory, and anti-apoptotic properties (Dorsey & 
Greespan, 2000; Ismail, Sestili, & Akhtar, 2012; Seeram et al., 2005; Vegara et al., 
2014). Antioxidants found in pomegranates have been found to be neuroprotective in 
mice with AD pathology (Tg2576) (Hartman et al., 2006). In this study, Hartman used a 
mere 1:20 diluted concentration of pomegranate juice and found significant behavioral 
and neuronal improvements. Mice that consumed the pomegranate-enriched water for 6 
months improved in spatial learning tasks and had significant reductions in hippocampal 
A42 and fibrillar A deposition. In another study, maternal supplementation with 
pomegranate juice influenced mice pup recovery after brain injury (Loren, Seeram, 
Schulman & Holtzman, 2005). Pregnant mice (C57BL6) received drinking water 
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containing high, moderate, or low doses of pomegranate juice concentrate. Hypoxic 
(oxygen deprivation) brain injury was induced 7 days after pups were born and sacrificed 
at 14 days old. Pups that were exposed to pomegranate juice neonatally, regardless of 
dose, had less tissue loss than controls, demonstrating the neuroprotective properties of 
pomegranate polyphenols. Another study also found that pomegranate juice 
supplementation ameliorated radiation induced depression-like behavior and improved 
motor performance in male mice (Dulcich & Hartman, 2013). In this study, Dulcich 
found the 1:20 dilution of juice that was given for 6 weeks to be extremely effective in 
irradiated mice.  
 
Grape Polyphenols 
Grapes are also high in polyphenolic properties and have been shown to have 
antioxidant and anti-inflammatory properties (Azachi, Yatuv, Katz, Hagay, & Danon, 
2014; Castilla et al., 2006; Greenspan et al., 2005; Marchi, Paiotti, Artigiani, Oshima, & 
Ribeiro, 2014; O’Byrne, Devaraj, Grundy, & Jialal, 2002; Singh, Agrawal, & Doré, 
2013). Several researchers have also focused on the beneficial effects prompted by the 
consumption of grapes and its derivatives (polyphenols, flavonoids, anthocyanins, and 
resveratrol) to ultimately reduce neuronal dysfunction and improve brain health.  
Darker varietals of grapes have higher polyphenolic content in their skin and 
seeds and are commonly used to produce wine and grape juice. Wine has been found to 
be neuroprotective in mice (Tg2576) with AD neuropathology (Wang et al., 2006). In this 
study, Wang found that consumption of cabernet sauvignon wine for 7 months lead 
significant improvements in spatial memory and reduced the overall A plaque burden in 
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the hippocampus and cortex. In a similar study, cabernet sauvignon treatment for 10 
months improved memory and also reduced A peptides in the brains of mice with AD 
neuropathology (Tg2576) (Ho et al. 2009). In another study, grape juice (Concord) 
protected against age-related deficits in rats (Schukitt-Hale, Carey, Simon, Mark, & 
Joseph, 2006). In this study, Schukitt-Hale found that rats given 10% and 50% grape 
juice for only 2 months improved in motor and learning tasks, respectively. In addition, 
grapes may also protect against oxidative damage (Ates et al., 2007) and increase 
hippocampal astrocyte activity (Fujishita et al., 2009). Increased astrocyte activity was 
also found in cells that were pre-treated with wine (Gomez-Serranillos et al., 2009).  
Resveratrol, a polyphenolic compound found in the skin of red grapes is thought 
to play a significant role in preventing neurotoxicity and inflammation in the brain 
(Milardi, Stringaro, Colone, Bonincontro, & Risuelo, 2014).  Mice pups that were treated 
with resveratrol 10 minutes and 24 hours prior to hypoxia had fewer inflammatory 
pathways activated than pups that were given resveratrol 3 hours post-injury (West, 
Atzeva & Holtzman, 2007). In another study, resveratrol significantly reduced 
inflammation and microglial activation in the hippocampus and cortex resveratrol when 
mice were injected 5 minutes and 12 hours post-TBI surgery (Gatson et al., 2012). In 
addition, resveratrol has also been found to influence AD neuropathology. For example, 
resveratrol prevented A aggregation, reduced oxidative species, and improved spatial 
memory in rats (Huang, Lu, Wo, Wu & Yang, 2011). Pre-treatment with resveratrol also 
led to stronger cell communication and viability in rat hippocampal slices that had been 
previously exposed to oxidative damage (Almeida et al., 2008). Resveratrol treatment 
also influenced AD neuropathology in mice. Mice (Tg19959; cross of APP695 with 
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KM670/671NL and V717F) that received resveratrol had a reduction in both diffuse and 
fibrillar A pathology in the medial cortex, striatum, and the hypothalamus 
(Karuppagounder et al., 2009). Similarly, human embryonic kidney 293 cells that were 
transfected with human APP695 for 2 days and incubated with resveratrol for 24 hours 
had more A peptide degradation than matched controls (Marambaud, Zhao & Davies, 
2005).  
Grape seed extract (GSE) is derived from whole grape seeds and contain a 
concentrated amount of vitamin E, flavonoids, and other polyphenols is also high in 
antioxidant and anti-inflammatory properties (Boghdady, 2013; Cai et al., 2011; Johnson-
Varghese, Brodsky, & Bhandari, 2004; Singh et al., 2013). The neuroprotective effects of 
GSE have been found to inhibit A formation (Ono et al., 2008) and reduce both A 
induced toxicity and reactive oxidative species (Li, Jang, Sun & Surh, 2004) in cultured 
cells. These findings have also been translated into AD animal models. In one study, 
mice (Tg2576) that consumed GSE (200 mg/kg/day) for 5 months had lower levels of 
reactive Aβ oligomeric species and showed improvement in spatial learning memory 
tasks (Wang et al., 2008). In another study, mice (PSAPP) that consumed a GSE enriched 
diet of 592.5 g/d over the course of 9 months had significant reductions in A plaque 
deposition in the neocortex and hippocampus, in addition to lower levels of microglial 
activity (Wang et al., 2009). Grape polyphenol extract was also found to ameliorate 
injury induced oxidative and neuronal damage (Wang et al., 2009). 
Diets enriched with high polyphenolic compounds can have a strong non-
pharmaceutical impact in attenuating cognitive decline and neurological diseases. Grapes 
and its derivatives have shown several neuroprotective effects resulting from the 
 24 
antioxidant and anti-inflammatory properties in the fruit. However, whether the inclusion 
of different types of grapes can prevent or slow down the combination of AD-related 
pathology and brain injury is not clear. In this study, we investigated the impact of a high 
polyphenol grape-enriched diet on cognitive and neuronal degeneration caused in PSAPP 
mice and brain injury.  
 
Aims of the Current Study 
 This study aimed to explore the potential neuroprotective effects of a high 
polyphenol grape diet in transgenic PSAPP mice and its influence on attenuating brain 
injury.  
o Aim 1: To determine whether a grape-enriched diet reduced lesion size from brain 
injury. 
o Hypothesis 1: Mice on the grape diet will have smaller lesions than mice on 
the control diet (main effect of diet). 
o Aim 2: To determine whether a grape-enriched diet and/or brain injury influenced 
behavior.  
o Hypothesis 2a: Mice on the grape diet will have fewer behavioral deficits 
than mice on the control diet (main effect of diet).  
o Hypothesis 2b: Mice with brain injury will have more behavioral deficits 
than control mice (main effect of injury).  
o Aim 3: To determine whether a grape-enriched diet and/or brain injury influenced 
AD neuropathology 
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o Hypothesis 3a: Mice on the grape diet will have lower Aβ levels than mice 
on the control diet (main effect of diet).  
o Hypothesis 3b: Mice with TBI will have more Aβ than naïve and sham mice 
(main effect of TBI).  
o Hypothesis 3c: TBI mice on the grape-enriched diet will have smaller 
lesions and less Aβ deposition than TBI mice on the control diet (diet x TBI 
interaction).   
o Aim 4: To determine whether a grape diet and/or brain injury influenced BBB 
clearance and astrogliosis. 
o Hypothesis 4a: Mice on the grape diet will have less RAGE and astrogliosis 
reactivity than mice on the control diet (main effect of diet).  
o Hypothesis 4b: Mice with TBI will have more RAGE and astrogliosis 
reactivity than naïve and craniotomy mice (main effect of TBI).  
o Hypothesis 4c: TBI mice on the grape-enriched diet will have less RAGE 
and astrogliosis than mice on the control diet (diet x TBI interaction).  
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CHAPTER TWO 
METHODS 
Experimental Design 
 Male and female mice (3 to 5 months old) were separated into 6 groups (diet/no-
diet, craniotomy/control, TBI/control), yielding a total of 12 groups (Table 1). Thirty-one 
animals were started on the grape-enriched diet immediately and continued on this diet 
until the time of sacrifice. The grape-enriched diet was packed into rodent pellets. Thirty-
one animals did not receive the grape rodent pellets, but received control sugar pellets.  
 
Table 1 
Projected animal group breakdown.  
 
 
 
 Animals were allowed to acclimate for 4 weeks before surgeries (anesthesia 
control, craniotomy, or CCI). After surgery, animals (craniotomy and CCI) underwent 
magnetic resonance imaging (MRI). Thereafter, all animals were tested a battery of 
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behavioral tests for 2 weeks. The tests assessed cognitive, motor, and learning abilities. 
After a total of 8 weeks, mice were perfused with paraformaldehyde via the left ventricle 
with saline until euthanization. Once euthanization was confirmed, the animals’ brained 
were removed and placed in paraformaldehyde for 24 hours, then washed in saline, 
frozen with dry ice, and stored at -20 degrees Celsius until sectioning. See Figure 2 for 
experimental timeline.   
 
 
 
Figure 2. Timeline of the experimental design.  
 
 
Animals 
 Sixty-one PSAPP (double transgenic mice exhibiting pathology similar to AD) 
mice between 3 to 5 months in age were obtained from Jackson Laboratories (Bar 
Harbor, ME) and divided into 4 groups (TBI vs. craniotomy controls, grape vs. none). 
Mice received either a control or grape-enriched diet for 8 weeks. The grape-enriched 
diet mice consumed a daily average of 0.5 mg of polyphenols from the grape powder in 
their food (15.5% by weight). The control diet contained sugars matching the caloric 
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context of the sugars in the grape diet (14% by weight). Previous research from our lab 
has shown 0.3-0.6 mg per day of dietary pomegranate polyphenols decreased Aβ levels 
and plaque load and improved behavior in Tg2576 mice (Hartman, et al., 2006). Four 
craniotomy and 6 CCI mice died before the completion of the study from injury related 
complications (See Table 2 for final group numbers). There were no significant weight 
differences between the groups.  
 
Table 2 
Final animal group breakdown. 
 
 
 
Grape-Enriched Diet 
 The California Table Grape Commission provided the freeze-dried grape powder. 
Red, green, and blue-black seeded and seedless grape varieties were used. These were 
frozen, ground with food-quality dry ice, freeze-dried, and then re-ground. The dry 
powder contained approximately 1% moisture and was stored at -70ºC in moisture-proof 
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containers. The compounds in the dry powder were similar as those found in fresh grapes 
such as catechins, anthocyanins, flavinols, and resveratrol. The grape powder was milled 
into Harlan Teklad 8640 High Protein Rodent Diet pellets (standard pellet is 3.2 Kcal/g). 
The grape-enriched diet had 15.5% (by weight) grape powder added to the pellet which 
included 18.3% of protein (22.9% of kcal), 51.4% of carbohydrates (64.4% of kcal), and 
4.5% of fat (12.7% of kcal). The control diet had 14% (by weight) sucrose added to the 
pellet which included 18.6% of protein (23.5% of kcal), 50.5% of carbohydrates (63.7% 
of kcal), and 4.5% of fat (12.7% of kcal).   
 
Traumatic Brain Injury Induction 
 After 4 weeks of dietary treatment, 20 animals underwent traumatic brain injury 
(controlled cortical impact) or sham surgery (TBI vs. sham, TBI with diet vs. TBI control 
diet), followed by two weeks for recovery. Surgeries were preformed as described in 
Brody et al. 2007. Briefly, animals were anesthetized with 3% isoflurane and local 
anesthetic (intradermal injection of lidocaine HCl 2% + 1:100,000 epinephrine). 
Following a midline incision, skim overlying the skull was retracted. A 5 mm craniotomy 
was induced in the right hemisphere (immediately adjacent to the Sagittal midline and 4.0 
mm anterior to Bregma). The heads of the mice were adjusted to allow the craniotomy to 
penetrate the thin skull without damaging the dura surrounding the brain. CCI was 
induced using an electromechanical impactor using a 3 mm tip. The CCI was delivered at 
a depth of 2.5 mm at a velocity of 5 m/s into the cortex; with a dwell time of 100 ms. 
After several mice began to die shortly following CCI, the depth of the injury was 
readjusted to 1.5 mm, with all other parameters remaining as before. Craniotomy mice 
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underwent similar surgery conditions with the exception that the impact tip only touched 
the dura matter, rather than directly impacting the cortex.  
 
Behavioral Testing 
 After 6 weeks of dietary treatment, all mice underwent a 2-week battery of 
behavioral tests to assess cognitive and motor abilities. Dietary treatment continued 
throughout testing until sacrifice.  
 
Open Field Activity 
General activity levels and movement patterns were assessed with an open field 
activity test, which involves the observation of an animal for 30 minutes in opaque open-
topped plastic boxes (49 x 36 cm). The movements of the animal were recorded with an 
overhead camera and analyzed by a computerized tracking system (Nodlus Ethovision). 
Examples of some of the parameters that were analyzed, including distance moved, 
percent time spent moving, movement velocity, path meander/tortuosity, and the number 
of rearings.  
 
Rotarod 
Sensorimotor and coordination were assessed with the accelerating rotarod 
(Columbus Instruments). This test consists of 4 rotating horizontal cylinders at a diameter 
of 3 cm. Mice are placed onto the cylinder and have to walk continuously forward to 
avoid falling. Latency to fall off is the dependent variable; with performance over days of 
testing is a measure of motor learning. Mice were tested every other day for 3 days. Three 
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blocks of 2 consecutive trials were administered per day: 2 stationary trials, 2 trials at 5 
RPM, and 2 trials that start at 10 RPM and increased by 2 RPM every 2 seconds.  
 
Elevated Zero Maze 
The elevated zero maze was used to assess exploratory behaviors in an anxiety-
provoking environment. The maze consisted of a plastic ring, with a 100 cm outer 
diameter, 10 cm wide. The two opposing quadrants were enclosed with 35 cm walls. The 
room was dimmed, and halogen lights directly illuminated the open spaces of the maze. 
Animals were placed in the center of one of the open spaces and allowed to freely explore 
the zero maze for 5 minutes. The percentage of time spent in the enclosed quadrants was 
calculated. Spending time in the enclosed spaces is generally associated with anxiety-like 
behavior. 
 
Water Maze 
Learning and memory were assessed with the water maze. This is a test of spatial 
navigation that requires an animal to learn the location of a hidden platform in a pool of 
water using the visual cues from around the room. The water maze consists of a large 
metal pool (110 cm diameter) filled with water that is colored opaque with white tempura 
paint. The pool contains a moveable platform (11 cm diameter) that the animal can step 
onto to escape the water. Animals were given a total of 10 trials per day. For each trial, 
animals were released with their nose against the wall into the pool at one of the 4 release 
points and were allowed to swim to the platform. The trials lasted a maximum of 60 
seconds and mice were manually guided to the platform if they did not find the platform 
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in time. An overhead camera recorded the swim paths which gathered data for the 
quantification of distance, latency, proximity to target, and swimming speed by a 
computerized tracking system (Nodlus Ethovision).  
On day 1, animals were given a cued water maze trial, which is a control task for 
assessing sensorimotor and/or motivational deficits that may affect performance during 
the spatial phase. The surface of the escape platform was visible (5 mm above the surface 
of the water) and a pole was placed on top of the platform to make its location more 
obvious. The location of the platform varied from trial to trial. Animals were released 
into the pool opposite the location of the platform and were allowed to remain on the 
platform for 5 seconds after finding it.  
On days 2-5, animals were given a spatial water maze, in which the mice were to 
find the platform based on its relationship to the spatial cues around the room, rather than 
direct visualization. The escape platform was submerged 1 cm below the surface of the 
opaque water and the location of the platform changed each day for 3 days. After finding 
the platform, animals were allowed to remain on there for an additional 5 seconds. The 
next day, animals were given a probe trial in which the platform was removed from the 
pool, and the animal was allowed to search for the platform for 60 seconds. Amount of 
time the animal spent in the probe quadrant was measured as well as the total number of 
times the animal crossed over the former location of the platform. An hour later, the 
platform was placed back into the pool at a new location, and the next sets of 10 trials 
were administered.   
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Tail Suspension Test 
 The tail suspension test was administered to assess depression-like behaviors. 
Mice were suspended by the tail with adhesive tape that was attached approximately 1 cm 
from the tip of the tail. The other end of the tape was wrapped around a hook that was 
embedded in the center of the ceiling of a wooden box (19 cm x 21 cm x 40 cm). Once 
suspended, the animal’s rostral end was approximately 20 cm from the floor of the box. 
The box was enclosed on all sides except for the viewing side, and lighting and sound in 
the room were kept at a minimum. Each animal received one 6-min trial and was rated on 
mobility and agitation for the duration of 6 minutes. The time that the animal remained 
immobile during the final 4 minutes of the trial was recorded. Immobility was defined as 
the complete lack of movement by the mouse, even if it was still swinging back and forth 
from a previous struggle or if it was curled up while holding its paws (as long as it was 
not struggling or moving otherwise). 
 
Tissue Preparation 
 After eight weeks of dietary treatment, mice were perfused through the heart with 
phosphate buffered saline (PBS), and brains were extracted. The right hemisphere of each 
brain was immediately removed, frozen at -80ºC and stored for future biochemical 
analyses. In preparation for histology and immunohistochemistry, the left hemisphere of 
each brain (n = 48) were immersed in 4% paraformaldehyde in 0.1 M PBS solution and 
stored at 4º C. Thereafter, the brain tissue was fixed in a 30% sucrose solution at 4º C for 
72 hours, followed by freezing on dry ice. The left hemispheres were cut as coronal 
cryostat sections (20 μm) at -20º C from the frontal cortex to the cerebellum (Fisher; 
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Leica CM1950; Leica Microsystems GmbH, Wetzlar, Germany). Brain tissue was 
directly mounted on glass slides (Gold Plus, Fisher) and stored at -20º C. Sectioning 
resulted in 50 slides per animal with 6-8 sections per slide. Each slide was a 
representation of the animal’s entire brain.  
 
Staining and Quantification Protocols 
Histology 
 Before beginning the staining protocol for each experiment, slides were removed 
from storage and were acclimated to room temperature (~20 minutes). Thereafter, each 
slide was placed on a warmer at 38˚C for 1 hour to ensure sections adhered to the slides 
well. Then slides were quickly dipped in double distilled water (ddH20) and were dried at 
room temperature for an additional 3 hours to prevent brain tissue from floating off 
during the protocol.  
 
Thioflavin-S  
 Slides were stained (20 naïve, 14 craniotomy, 10 CCI) with thioflavin-S to detect 
fibrillar Aβ, as previously described (DeMattos et al., 2002). Thioflavin-S was removed 
from 4˚C to acclimate to room temperature. Slides were washed in 3 consecutive 5-
minute washes of phosphate buffered saline (PBS; pH 7.4; Fisher Scientific, Pittsburgh, 
PA) to remove any mounting medium surrounding the brain sections. After, slides 
underwent two 5-minute washes of ddH20 to acclimate brain sections to ddH20 because 
thioflavin-S is water based. The following procedures were completed inside a hood in 
the dark to keep the stain’s fluorescent properties intact. Slides were stained in 1% 
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thioflavin-S solution for 5 minutes, followed by washes in 70% ethanol (EtOH) 2 x 3 
minutes and 90% EtOH 1 x 3 minute. Ethanol steps were used to increase the 
differentiation of the stain and to lower background fluorescence. Brain tissue from 2 
naïve and 1 sham slides floated off during the staining protocol and could not be used for 
analysis. Once sections were dry, slides were cover-slipped with anti-fading medium 
(Vectashield; Vector Laboratories, Burlingame, CA) containing 4,6-diamino-2-
phenylindole (DAPI), which stained cell nuclei. Slides were sealed with clear nail polish 
and were stored in a slide box at 4˚C for analysis.  
 
Quantification of Thioflavin-S 
  Quantification of fibrillar Aβ plaque load was assessed using the Mercator 
software (Explora-Nova, La Rochelle, France) with an epifluorescence microscope 
(Olympus, BX41, Center Valley, PA USA). All of the analytical procedures were 
completed in the dark to protect the fluorescent properties of the stain. Slides were 
removed from storage one at a time and were cleaned with 70% EtOH on Kim wipes to 
remove any dust or fingerprints. One section per slide (Bregma level ~ -1.94 mm; Figure 
2B) was analyzed to ensure consistency among results. The hippocampus and dorsal 
cortex regions were manually outlined, as regions of interest and the threshold and user-
defined parameters were kept consistent for all animals. Once completed, false positives 
(i.e. vessels or dust) were double checked and manually deleted in the hippocampus and 
dorsal cortex regions. Using the region statistics that were automatically generated in the 
program, the % fibrillar Aβ plaque load was calculated.  
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Quantification of Brain Area 
 Slides stained with thioflavin-S were used to quantify brain area with the 
Mercator software (Explora-Nova, La Rochelle, France) on the microscope. Brain 
sections at Bregma level -1.94 mm on each slide were outlined. In addition, the ventricles 
and open spaces on the brain section were outlined and subtracted from the brain area.  
 
Immunohistochemistry 
 For all the immunohistochemistry experiments, slides were removed from storage 
at -20˚C to acclimate to room temperature. Once acclimated (~20 minutes), each slide 
was placed on a warmer at 38˚C for 1 hour to ensure sections adhered well. Slides were 
quickly dipped in ddH20 and were dried at room temperature for an additional 3 hours to 
prevent brain tissue from floating off during washes and staining. 
 
Monoclonal HJ3.4 Amyloid Beta Antibody 
Slides were stained (20 Naïve, 14 craniotomy, 12 CCI) with the HJ3.4 antibody to 
detect all confirmations of A, (kindly provided by John Cirrito at the Washington 
University, St. Louis, MO). This antibody binds to the central domain of A and has a 
secondary fluorescent tag already attached to the primary. Slides underwent washes of 
PBS 2 x 10 minutes, followed by outlining the tissue with a Dako pen to create a 
boundary for the antibody to stay within. Brain sections were blocked at room 
temperature in a humid chamber for 90 minutes in 1% bovine serum albumin (BSA) in 
PBS (Sigma-Aldrich Co., St. Louis, MO). Next, slides were incubated overnight at 4ºC 
with HJ3.4 antibody (mouse, 1:1000; Washington University School of Medicine, St. 
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Louis, MO) in 0.25% BSA/0.25% TritonX-100 in PBS (Sigma-Aldrich Co., St. Louis, 
MO). The next day, slides were rinsed in PBS 2 x 10 minutes, followed by washes in 
ddH20 2 x 1 minute to remove PBS salts. Once sections were dry, they were cover-
slipped with Vectashield containing DAPI, sealed with clear nail polish, and stored in a 
slide box at 4˚C for analysis.  
 To further optimize staining, a formic acid (88%) antigen retrieval technique was 
used. Slides underwent washes of PBS 2 x 10 minutes, followed by outlining the tissue 
with a Dako pen to create a boundary for the formic acid to stay within. Formic acid was 
added to cover each tissue section (~2 drops) for 4 minutes. Slides were immediately 
washed with PBS to stop formic acid activity, followed by 3 x 10 minutes of PBS 
washes. Brain sections were blocked at room temperature in a humid chamber for 90 
minutes in 1% BSA in PBS (Sigma-Aldrich Co., St. Louis, MO). Next, slides were 
incubated overnight at 4ºC with HJ3.4 antibody (mouse, 1:1000; Washington University 
School of Medicine, St. Louis, MO) in 0.25% BSA/0.25% TritonX-100 in PBS (Sigma-
Aldrich Co., St. Louis, MO). The next day, slides were rinsed in PBS 2 x 10 minutes, 
followed by washes in ddH20 2 x 1 minute to remove PBS salts. Once sections were dry, 
they were cover-slipped with Vectashield containing DAPI, sealed with clear nail polish, 
and stored in a slide box at 4˚C for analysis. There were no significant differences in 
staining between tissues that underwent formic acid treatment to those that did not 
receive antigen retrieval.  
 In another attempt to optimize staining, a citrate buffer (10mM citric acid, 0.05% 
tween 20, pH 6.0) antigen technique was used. Slides underwent washes of PBS 2 x 10 
minutes, and placed in the citrate buffer solution.  Slides in the buffer solution were 
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heated in the microwave for 5 minutes and were allowed to cool to room temperature. 
Once cooled, slides underwent 2 x 10 minutes PBS washes, followed by outlining the 
tissue with a Dako pen to create a boundary for the blocking solution. Brain sections were 
blocked at room temperature in a humid chamber for 90 minutes in 1% BSA in PBS 
(Sigma-Aldrich Co., St. Louis, MO). Next, slides were incubated overnight at 4ºC with 
HJ3.4 antibody (mouse, 1:1000; Washington University School of Medicine, St. Louis, 
MO) in 0.25% BSA/0.25% TritonX-100 in PBS (Sigma-Aldrich Co., St. Louis, MO). 
The next day, slides were rinsed in PBS 2 x 10 minutes, followed by washes in ddH20 2 x 
1 minute to remove PBS salts. Once sections were dry, they were cover-slipped with 
Vectashield containing DAPI, sealed with clear nail polish, and stored in a slide box at 
4˚C for analysis. There were no significant differences in staining between tissues that 
underwent citrate buffer treatment to those that did not receive antigen retrieval. 
 
Quantification of HJ3.4 
 Quantification of global Aβ plaque load was assessed using the Mercator software 
(Explora-Nova, La Rochelle, France) with an epifluorescence microscope (Olympus, 
BX41, Center Valley, PA USA). All of the analytical procedures were completed in the 
dark to protect the fluorescent properties of the stain. Slides were removed from storage 
one at a time and were cleaned with 70% EtOH on Kim wipes to remove any dust or 
fingerprints. One section per slide (Bregma level ~1.70 mm, ~ -1.94 mm, and ~ -3.52 
mm; Figure 3) was analyzed to ensure consistency among results. The hippocampus and 
dorsal cortex regions were manually outlined, as regions of interest and the threshold and 
user-defined parameters were kept consistent for all animals. Once completed, false 
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positives (i.e. vessels or dust) were double checked and manually deleted in the 
hippocampus and dorsal cortex regions. Using the region statistics that were 
automatically generated in the program, the % Aβ plaque load was calculated. 
 
 
 
 
Figure 3. Bregma levels in the brain. (A) The entire cortical surface of the brain section 
at Bregma ~1.70 mm was analyzed for global Aβ plaque load. (B) The hippocampus and 
the overlying dorsal cortical surface of the brain section at Bregma ~ -1.94 mm was 
analyzed for global Aβ and fibrillar Aβ plaque load. (C) The cortical surface immediately 
lateral to the hippocampus at Bregma ~ -3.52 mm was analyzed for global Aβ plaque 
load.  
 
 
 
Glial Fibrillary Acidic Protein Antibody 
 Glial fibrillary acidic protein (GFAP) antibody was used to assess the astroglial 
immunoreactivity in the dorsal parietal cortex. Expressed in the central nervous system, 
GFAP is an intermediate filament protein that is believed to help maintain astrocyte 
mechanical strength and shape expressed in astrocytes. Twenty naïve, 14 craniotomy, and 
12 CCI slides were stained. Slides underwent washes in PBS 2 x 10 minutes, followed by 
outlining the tissue with a Dako pen. Brain sections were blocked at room temperature in 
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a humid chamber for 90 minutes in 1% BSA in PBS. Next, slides were incubated 
overnight at 4ºC with the primary (1º) antibody (GFAP; chicken, 1:1000, Millipore, 
Massachusetts) in 0.25% BSA/0.25% TritonX-100 in PBS. The next day, slides were 
rinsed in PBS 2 x 10 minutes, followed by incubation in a humid chamber with the 
secondary (2º) antibody (anti-chicken, 1:1000, Odyssey, coupled with Alexa-Flur-680 for 
infra-red analysis) in 0.25% BSA/0.25% TritonX-100 in PBS at room temperature for 90 
minutes. To decrease background and remove excess 2º, slides were rinsed in PBS 3 x 10 
minutes. After, slides were rinsed in ddH20 2 x 1 minute to remove the PBS salts. Once 
sections were dry, they were cover-slipped with Vectashield containing DAPI, sealed 
with clear nail polish, and stored in a slide box at 4˚C for analysis. Brain tissue from 2 
naïve and 2 sham slides floated off during the staining protocol and could not be used for 
analysis.  
 
Receptor for Advanced Glycation Endproducts Antibody 
 Receptor for advanced glycation endproducts (RAGE) labeling will be used to 
measure the influx of peripheral Aβ peptides across the BBB into the brain. Twenty 
naïve, 14 craniotomy, and 12 CCI slides were stained. Slides were washed in PBS 2 x 10 
minutes, followed by outlining the tissue with a Dako pen. Brain sections were blocked at 
room temperature in a humid chamber for 90 minutes in 1% BSA in PBS. Next, slides 
were incubated overnight at 4ºC with the 1º antibody (RAGE; rabbit, 1:1000, Abcam, 
Massachusetts) in 0.25% BSA/0.25% TritonX-100 in PBS. The next day, slides were 
rinsed in PBS 2 x 10 minutes, followed by incubation in a humid chamber with the 2º 
antibody (anti-rabbit, 1:1000, Rockland Immunochemicals Inc., PA) coupled with Alexa-
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Flur-800 for infra-red analysis) in 0.25% BSA/0.25% TritonX-100 in PBS at room 
temperature for 90 minutes. To decrease background and remove excess 2º, slides were 
rinsed in PBS 3 x 10 minutes. In addition, slides went through washes in ddH20 2 x 1 
minute to remove the PBS salts. Once sections were dry, slides were cover-slipped with 
Vectashield containing DAPI, sealed with clear nail polish, and stored in a slide box at 
4˚C for analysis. Brain tissue from 2 naïve and 2 sham slides floated off during the 
staining protocol and could not be used for analysis.  
 
Quantification of GFAP and RAGE 
 The Licor-Odyssey scanner detects the secondary antibodies by recording the 
intensity of the infrared signal through a photomultiplier. The photomultiplier is used to 
precisely detect light by multiplying the current produced by a light millions of times, 
allowing individual photons to be detected and visible on an image. The intensities of the 
cytoplasm of the neurons were analyzed using the red (700 nm) and green (800 nm) 
channels. Each slide was scanned into the program using the same parameters for all the 
brain tissue at 21µm/pixel resolution, 3.0 intensity for GFAP, and 6.0 intensity for RAGE 
(Licor Bio-Science, Lincoln, NE). The averaged intensity (I.I.) scores were obtained from 
five independent fields-of-interest drawn close to one another with the Licor-Odyssey 
analysis software on the cortex directly adjacent to the hippocampus (Bregma level ~ -
1.94 mm). The specific region of the dorsal parietal cortex was chosen for because this 
are was present on all the animals, in contrast to the hippocampus. Pixel intensities 
ranged from 0 (dark) to 255 (light), in which lower pixel intensities represented lower 
density and immunoreactivity. 
 42 
Statistical Analysis 
 IBM SPSS 21 was used to analyze data. An α-level of 0.05 was used for all 
statistical significance tests. Correlations between behavioral, histology, and 
immunohistochemistry variables were determined using the Pearson product-moment 
coefficient. Data from all behavioral testing, histology and immunohistochemistry 
staining were analyzed with one-way analysis of variances (ANOVAs; group: control vs. 
grape, injury, gender). Two-way ANOVAs with two between-subjects factors were used 
to further distinguish any group interactions. Swim data from the water maze was 
analyzed by averaging trials into 5 blocks of 2 trials each. These blocks were analyzed 
with repeated measure ANOVAs that included one within-subjects variable (test day). 
Probe swim data were analyzed by averaging all 3 trials. To avoid violating the 
assumptions of compound symmetry and sphericity, the reported p-values for every 
repeated-measures analysis reflected the Huynh-Feldt adjustment to the degrees of 
freedom. Graphs were created using the Prism 6.0 statistical program. 
 The procedures and necessary equipment described above were available and 
routinely used by the Badaut laboratory at Loma Linda University.   
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CHAPTER THREE 
RESULTS 
Aim 1: Influence of a Grape-Enriched Diet on Lesion Size 
 Structural MRI data revealed that TBI mice (M = 5.79, SD = 1.78) produced a 
larger brain injury than craniotomy mice (M = 1.81, SD = .94), F(1, 26) = 58.82, p < .01; 
Figure 3A. There was no overall effect of diet on brain lesion (p > .05; Figure 4B). 
Craniotomy mice on the enriched diet had smaller and more consistent lesions than 
control, though results did not reach statistical significance (p > .05; Figure 4C).  
 
 
 
 
Figure 4. Percentage of lesion volume was determined using structural MRI data. (A) 
TBI in mice resulted in larger percentages of brain lesioned than those with craniotomy 
(p < .01). (B) Overall, grape-enriched diet did not influence the percentage of brain 
lesioned (p > .05). (C) Grape-enriched craniotomy had smaller percentages of brain 
damage compared to control, though these results did not reach statistical significance (p 
> .05).   
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Aim 2: The Influence of a Grape-Enriched Diet and/or Brain Injury on Behavior 
Influence of Diet on Behavior 
General exploratory behaviors were assessed in open field testing. Overall, diet 
did not influence hyperactivity or exploratory behaviors in open field testing (p > .05; 
Figure 5, 6).  
 
 
 
Figure 5. Diet did not influence general activity levels. (A) The enriched diet did not 
affect the percentage of time mice spent moving during the test (p > .05). (B) The 
enriched diet did not affect the distance mice traveled (p > .05). (C) The enriched diet did 
not affect the velocity of mice during exploration (p > .05). (D) Diet did not influence the 
percentage of time spent in the perimeter of open field box (p > .05).  
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Figure 6. Diet did not influence general activity levels. (A, B) Diet did not affect the 
percentage of time spent exploring in the center or corner of the open field test (p > .05).  
 
Sensorimotor and coordination were tested with the rotarod. Overall, the grape-
enriched diet did not improve performance on the rotarod (p > .05; Figure 7). 
Performance did not improve on day 2 of testing in either the steady or accelerating 
rotarod trials (p > .05; Figure 7). 
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Figure 7. (A, B) The grape-enriched diet did not influence motor performance on the 
steady trials of the rotarod across both days of testing (p > .05). (C, D) The grape-
enriched diet did not influence motor performance on the accelerating rotarod trials 
across both days of testing (p > .05). 
 
 
However, craniotomy mice on the grape-enriched diet showed significant behavioral 
improvements. Grape-enriched mice stayed on the more difficult accelerating and faster 
rotarod trials longer on day 1 of testing, though results did not reach statistical 
significance (Figure 8).  
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Figure 8. Grape-enriched diet influenced motor behavior in craniotomy mice. (A) 
Craniotomy mice on the enriched diet had a longer latency to fall of the rotarod, though; 
results did not reach statistical significance (p > .05). (B) Craniotomy mice on the 
enriched diet had a longer latency to fall off the rotarod during the most difficult trial, 
however, these results did not reach statistical significance (p > .05). 
 
The grape-enriched diet did not influence motor performance on the fast, more 
challenging, rotarod trail across days of testing (p > .05; Figure 9). 
 
 
 
Figure 9. Diet did not influence motor coordination. (A, B) The grape-enriched diet did 
not affect overall motor performance on the fastest trials of the rotarod (p > .05).  
 
 Anxiety-like behaviors were assessed with the elevated zero maze. Diet did not 
affect the time animals spent in the dark portion of the maze on both days of testing (p > 
.05; Figure 10). In addition, performance did not change on day 2 (p > .05).  
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Figure 10. Diet did not improve anxiety-like behaviors. (A) The grape-enriched diet did 
not influence the percentage of time mice spent in the dark on day 1 of the zero maze (p > 
.05). (B) The grape-enriched diet did not influence the percentage of time mice spent in 
the dark on day 2 of the zero maze (p > .05). (C) Overall, the enriched diet did not affect 
the average time spent in the dark in the zero maze (p > .05). 
 
Learning and memory were assessed with the water maze. Diet did not affect 
learning and memory deficits in the cued water maze trials (p > .05; Figure 11).  
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Figure 11. Diet did not influence performance on the cued water maze. (A, C, D) The 
grape-enriched diet did not affect the distance traveled in the water maze (p > .05). (B) 
The grape-enriched diet did not influence the time in locating the platform in the water 
maze (p > .05).  
 
 
 
Similarly, diet did not affect the distance moved (Figure 12), time to platform (Figure 
13), cumulative distance to the platform (Figure 14), average distance to the platform 
(Figure 15), swim speed (Figure 16), and turn bias (Figure 17) in the spatial water maze 
(p > .05).  
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Figure 12. Diet did not affect spatial water maze performance. (A) The grape-enriched 
diet did not affect the distance mice moved in the spatial 1 water maze (p > .05). (B) The 
grape-enriched diet did not affect the distance mice moved in the spatial 2 water maze (p 
> .05). (C) The grape-enriched diet did not affect the distance mice moved in the spatial 3 
water maze (p > .05).  
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Figure 13. Diet did not affect the time it mice took to find the submerged platform in the 
water maze. (A) Grape-enriched mice did not find the submerged platform faster than 
control in the spatial 1 water maze (p > .05). (B) Grape-enriched mice did not find the 
submerged platform faster than control in the spatial 2 water maze (p > .05). (C) Grape-
enriched mice did not find the submerged platform faster than control in the spatial 3 
water maze (p > .05).  
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Figure 14. Diet did not affect the cumulative distance mice traveled in the water maze. 
(A) Mice on the grape-enriched diet did not travel a shorter distance compared to control 
in the spatial 1 water maze (p > .05). (B) Mice on the grape-enriched diet did not travel a 
shorter distance compared to control in the spatial 2 water maze (p > .05). (C) Mice on 
the grape enriched-diet did not travel a shorter distance compared to control in the spatial 
3 water maze (p > .05). (D) Mice on the grape-enriched diet did not travel a shorter 
distance in the averaged probe trials in the water maze (p > .05).  
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Figure 15. Diet did not affect the average distance traveled to the submerged platform in 
the water maze. (A) Mice on the enriched-grape diet did not travel a shorter distance to 
the platform than control in the spatial 1 water maze (p > .05). (B) Mice on the enriched-
grape diet did not travel a shorter distance to the platform than control in the spatial 2 
water maze (p > .05). (C) Mice on the grape-enriched diet did not travel a shorter distance 
to the platform than control in the spatial 3 water maze (p > .05). (D) Mice on the grape-
enriched diet did not travel a shorter distance to the platform than control in the probe 
water maze trials (p > .05).   
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Figure 16. Diet did not influence turn bias in the water maze. (A) The grape-enriched diet 
did not affect turn bias in the spatial 1 water maze (p > .05). (B) The grape-enriched diet 
did not affect turn bias in the spatial 2 water maze (p > .05). (C) The grape-enriched diet 
did not affect turn bias in the spatial 3 water maze (p > .05). (D) The grape-enriched diet 
did not affect turn bias in the probe water maze (p > .05).  
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Figure 17. Diet did not affect swim speed in the water maze. (A) The grape-enriched diet 
did not affect velocity in the spatial 1 water maze (p > .05). (B) The grape-enriched diet 
did not affect velocity in the spatial 2 water maze (p > .05). (C) The grape-enriched diet 
did not affect velocity in the spatial 3 water maze (p > .05). (D) The grape-enriched diet 
did not affect velocity in the probe water maze (p > .05).  
 
 
 
Depression-like behaviors were tested with the tail suspension test. Overall, the 
grape-enriched diet had no affect on depression-like behaviors, regardless of injury (p > 
.05; Figure 18).  
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Figure 18. Diet did not influence depression-like behaviors. (A) The grape-enriched diet 
did not affect the amount of time mice spent immobile in the tail suspension test (p > 
.05). (B) The grape-enriched diet did not affect the amount of time mice spent immobile 
during the last 4 minutes in the tail suspension test (p > .05). (C) The grape-enriched diet 
did not affect the time mice first “gave up” in the tail suspension test (p > .05).  
 
 
However, when looking at TBI alone, diet displayed a significant role in 
depression-like behaviors. Surprisingly, TBI mice on the enriched diet (M = 17.58, SD = 
4.10) spent more time immobile on the tail suspension test than those on the control diet 
(M = 31.62, SD = 11.03), F(1, 8) = 5.75, p < .05; Figure 19). 
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Figure 19. Grape-enriched diet influenced depression-like behaviors. (A) The grape-
enriched diet did not affect the amount of time all mice spent immobile (p > .05). (B) The 
grape-enriched diet induced depression-like behaviors in TBI mice, where these mice 
spent more time immobile on the test than controls (p < .05).  
 
 
The Influence of Injury on Behavior 
 Brain injury did not affect general anxiety and exploratory patterns in open field 
testing (p > .05; Figure 20, 21).   
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Figure 20. Brain injury did not alter general exploratory activity levels. (A) Naive, 
craniotomy, and CCI mice did not differ in the percentage of time spent moving in open 
field testing (p > .05). (B) Naïve, craniotomy, and CCI mice did not differ in the amount 
of distance traveled in open field testing (p > .05). (C) Naïve, craniotomy, and CCI mice 
did not differ in velocity in open field testing (p > .05). (D) Naïve, craniotomy, and CCI 
mice did not differ in the percentage of time spent in the perimeter of the open field 
testing (p > .05).  
 
 
 
 
Figure 21. Brain injury did not alter general activity levels. (A) Naïve, craniotomy, and 
CCI mice did not differ in the percentage of time spent in the center of the test (p > .05). 
(B) Naïve, craniotomy, and CCI mice did not differ in the percentage of time spent in the 
corner of the test (p > .05).  
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Gender did not influence anxiety and exploratory patterns (Figure 22, 23); 
however, female mice trended towards exploring the test at a higher velocity than males 
(p < .01; Figure 19C). More specifically, naïve female (M = 7.04, SD = .66) mice were 
more hyperactive, exploring the test at a higher velocity than naïve males (M = 6.41, SD 
= .52) (F(1, 18) = 5.53, p < .05; data not shown).  
 
 
 
Figure 22. General exploratory activity levels were not influenced by gender. (A) Male 
and female mice did not differ in the percentage of time mice spent moving during open 
field testing (p > .05). (B) Male and female mice did not differ in the amount of distance 
traveled during open field testing (p > .05). (C) Female mice trended towards traveling at 
a higher velocity during testing than males (p = .06). (D) Male and female mice did not 
differ in the percentage of time mice spent in the perimeter of the test.  
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Figure 23. General exploratory activity levels were not influenced by gender. (A) Male 
and female mice did not differ in the percentage of time mice spent in the center of the 
test (p > .05). (B) Male and female mice did not differ in the percentage of time mice 
spent in the corner of the test (p > .05).  
 
 Brain injured animals exhibited motor deficits on the rotarod. Although 
differences were not found on day 1 (Figure 24A, 24C), day 2 of testing revealed injury 
dependent impaired performance. Craniotomy (M = 30.77, SD = 16.66) and CCI (M = 
28.64, SD = 16.38) mice fell off the steady rotarod trial more quickly than naïve mice (M 
= 43.41, SD = 13.73) (F(2, 45) = 4.46, p < .05; Figure 24B). On the more challenging 
accelerating rotarod trial on day 2, CCI (M = 17.87, SD = 4.95) mice fell off more 
quickly than naïve (M = 24.80, SD = 8.41) (F(2, 45) = 3.97, p < .05; Figure 24D).   
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Figure 24. Motor deficits were evident on the rotarod. (A) Differences between naïve, 
craniotomy, and CCI mice were not detected on day 1 of the steady rotarod trial (p > .05). 
(B) Craniotomy (p < .05) and CCI (p < .05) mice fell off the rotarod on day 2 more 
quickly than naïve. (C) Differences between naïve, craniotomy, and CCI mice were not 
detected on day 1 of the accelerating rotarod trial (p > .05). (D) CCI (p < .05) mice fell 
off the accelerating rotarod on day 2 more quickly than naïve.  
 
 
Similar results were observed on day 2 of the most challenging rotarod test. Craniotomy 
(M = 15.30, SD = 6.86) and CCI (M = 13.56, SD = 4.03) mice fell off the trial more 
quickly than naïve mice (M = 19.99, SD = 5.64) (F(2, 45) = 5.06, p < .01; Figure 25B).  
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Figure 25. Motor deficits were evident on the rotarod. (A) Differences between naïve, 
craniotomy, and CCI were not detected on day 1 of the faster rotarod trial (p > .05). (B) 
Craniotomy (p < .05) and CCI (p < .05) mice fell off the fast rotarod trial on day 2 more 
quickly than naïve. 
 
 Male and female mice did not differ in performance on the steady (Figure 26), 
accelerating (Figure 26), and faster (Figure 27) rotarod trials on day 1 and 2 (p > .05).  
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Figure 26. Motor performance was not influenced by gender. (A, B) Male and female 
mice did not differ in performance on the steady rotarod trials on day 1 and 2 (p > .05). 
(C, D) Male and female mice did not differ in performance on the accelerating rotarod 
trials on day 1 and 2 (p > .05).  
 
 
 
 
 
Figure 27. Motor performance was not influenced by gender. (A, B) Male and female 
mice did not differ in performance on the faster rotarod trial on day 1 or 2 (p > .05).  
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 General anxiety behaviors were assessed with the elevated zero maze. The 
performance of the maze did not differ between naïve, craniotomy, and CCI mice (p > 
.05; Figure 28). Similarly, gender did not affect the performance in the zero maze (p > 
.05; Figure 29).  
 
 
 
Figure 28. Mice did not differ in anxiety-like behaviors. (A) Naïve, craniotomy, and CCI 
mice did not differ in the percentage of time spent in the dark in the zero maze on day 1 
(p > .05). (B) Naïve, craniotomy, and CCI mice did not differ in the percentage of time 
spent in the dark in the zero maze on day 2 (p > .05). Overall, mice did not differ in the 
average percentage of time spent in the dark (p > .05).  
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Figure 29. Male and female mice did not differ in anxiety-like behaviors. (A) Mice did 
not differ in the percentage of time they spent in the dark on day 1 of the zero maze (p > 
.05). (B) Mice did not differ in the percentage of time they spent in the dark on day 2 of 
the zero maze (p > .05). (C) Overall, mice did not differ in the average percentage of time 
spent in the dark (p > .05).  
 
 
 
Brain injury produced severe learning deficits in the cued water maze. Both CCI 
(M = 645.87, SD = 142.83) and craniotomy (M = 498.43, SD = 220.57) mice performed 
worse on the cued water maze by swimming longer distances compared to naïve (M = 
359.08, SD = 120.09) (F(2, 45) = 9.98, p < .01; Figure 30A). CCI (M = 34.53, SD = 
10.00) and craniotomy (M = 34.53, SD = 10.00) mice took longer to find the platform 
than naïve (M = 18.99, SD = 6.80) (F(2, 45) = 9.94, p < .01; Figure 30C), and CCI (M = 
10017.23, SD = 3605.78) mice showed no evidence of learning the platform’s location 
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compared to naïve (M = 5572.91, SD = 2340.52) (F(2, 45) = 7.18, p < .01; Figure 30B). 
Injury severity did not affect the average distance to the platform (p > .05; Figure 30D).  
 
 
 
Figure 30. Brain injury induced significant learning deficits in the cued water maze. (A) 
Both CCI (p < .01) and craniotomy (p < .05) mice searched the maze more than naïve 
mice. (B) CCI mice had a cumulative distance to the platform than naïve mice (p < .01). 
(C) Both CCI (p < .01) and craniotomy (p < .05) mice took longer to find the platform 
than naïve mice. (D) Injury severity did not affect the average distance to the platform (p 
> .05). 
 
 Gender did not affect performance in the cued water maze (p > .05; Figure 31). 
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Figure 31. Gender did not influence water maze performance. (A) Male and female mice 
did not differ in the distance traveled in the cued water maze (p > .05). (B) Male and 
female mice did not differ in the time it took to locate the platform in the cued water 
maze (p > .05). (C) Male and female mice did not differ in the cumulative swim distance 
to the platform in the cued water maze (p > .05). (D) Male and female mice did not differ 
in the averaged distance to the platform in the cued water maze (p > .05).  
 
 
 
Learning and memory were assessed in the spatial water maze. Naïve, 
craniotomy, and CCI mice did not differ in the distance traveled in the spatial water maze 
(p > .05; Figure 32).  
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Figure 32. Distance traveled was not influenced by injury in the water maze. (A) Naïve, 
craniotomy, and CCI mice did not differ in the distance moved in the spatial 1 water 
maze (p > .05). (B) Naïve, craniotomy, and CCI mice did not differ in the distance moved 
in the spatial 2 water maze (p > .05). (C) Naïve, craniotomy, and CCI mice did not difer 
in the distance moved in the spatial 3 water maze (p > .05).   
 
 
 
CCI mice (M = 36.91, SD = 11.53) performed worse compared to naïve (M = 26.20, SD = 
9.23) when the platform’s location was changed on day 2 of the water maze, F(2, 45) = 
4.52, p < .05; Figure 33A. These differences were minimized on day 3 of the water maze 
(Figure 33B), but returned on day 4 (Figure 32C). CCI mice (M = 37.49, SD = 3.41) 
performed worse compared to naïve (M = 26.15, SD = 2.77) when the platform was 
changed on day 4 of the water maze, F(2, 45) = 482.38, p < .05; Figure 33C.  
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Figure 33. Learning and memory deficits were evident in the water maze. (A) CCI mice 
took longer to locate the submerged platform than naïve mice on day 1 of the spatial 
water maze (p < .05). (B) Mice did not differ in the time it took to locate the platform on 
day 2 of the spatial 2 water maze (p > .05). (C) CCI mice took longer to locate the 
submerged platform than naïve mice on day 3 of the spatial water maze (p < .05).  
 
 
 
CCI mice (M = 9029.57, SD = 1053.06) traveled a longer cumulative distance to the 
platform compared to naïve (M = 6022.30, SD = 584.41) on day 1 of the spatial water 
maze, F(2, 45) = 4.15, p < .05; Figure 34A. These differences were minimized on day 2 
of the spatial water maze (Figure 34B), but returned in spatial 3 (Figure 34C) and probe 
trials (Figure 34C) of the water maze. CCI mice (M = 11151.42, SD = 1476.66) traveled a 
longer cumulative distance to the platform compared to naïve (M = 6397.08, SD = 
679.68) in the spatial 3 water maze, F(2, 45) = 5.07, p < .01; Figure 34C. Similarly, CCI 
mice (M = 45.83, SD = 1.13) traveled a greater cumulative distance to the platform 
 70 
compared to naïve (M = 39.45, SD = 1.35) in the probe trials, F(2, 45) = 5.03, p < .01; 
Figure 34D. 
 
 
 
Figure 34. Learning and memory deficits were evident in the water maze. (A) CCI mice 
swam longer distances to locate the submerged platform than naïve in the spatial 1 water 
maze (p < .05). (B) There were no differences in swim distance in the spatial 2 water 
maze (p > .05). (C) CCI mice swam longer distances to locate the platform than naïve in 
the spatial 3 water maze (p < .01). (D) CCI mice swam longer distances in search of the 
platform than naïve in the probe trials (p < .01).  
 
 
 
CCI mice (M = 36.34, SD = 1.78) swam a longer distance to the platform than naïve (M = 
31.65, SD = 1.12) in the spatial 1 water maze, F(2, 45) = 3.51, p < .05; Figure 35A. These 
differences were not found in the spatial 2 water maze (Figure 35B), but returned in the 
spatial 3 and probe trials. CCI mice (M = 44.27, SD = 2.48) swam a longer distance to the 
platform than naïve (M = 36.57, SD = 0.83) in the spatial 3 water maze, F(2, 45) = 5.63, p 
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< .01; Figure 35C. Similarly, CCI mice (M = -4.48, SD = 1.78) swam longer distances to 
the platform than naïve (M = -0.75, SD = 0.43) in the probe trials, F(2, 45) = 6.24, p < 
.01; Figure 35D.  
 
 
 
Figure 35. Learning and memory deficits were evident in the water maze. (A) CCI mice 
swam longer distances to find the platform than naïve in the spatial 1 water maze (p < 
.05). (B) There were no differences between injury groups in the spatial 2 water maze p > 
.05. (C) CCI mice swam longer distances to find the platform than naïve in the spatial 3 
water maze (p < .01). (D) CCI mice swam longer distances to find the platform than 
naïve in the probe trials of the water maze (p < .01).   
 
 
 
Overall, CCI mice had a significant left sided turn bias in the water maze. CCI mice (M = 
-39.08, SD = 15.77) swam with a significant left sided turn bias compared to naïve (M = 
3.09, SD = 6.22) and craniotomy (M = -3.70, SD = 6.12) in the spatial 1 water maze, F(2, 
45) = 5.65, p < .01; Figure 36A). CCI mice (M = -31.48, SD = 14.37) swam with a 
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significant left sided turn bias compared to naïve (M = -0.15, SD = 4.66) in the spatial 2 
water maze, F(2, 45) = 3.84, p < .05; Figure 36B). CCI mice (M = -34.65, SD = 15.91) 
swam continued to swim with a left sided turn bias in the spatial 3 water maze compared 
to naïve (M = -2.25, SD = 6.12), F(2, 45) = 3.10, p < .05; Figure 36C). CCI mice (M = -
39.74, SD = 16.42) also swam with a left sided turn bias in the probe trials compared to 
naïve (M = -2.42, SD = 5.50) and craniotomy (M = -7.56, SD = 5.21), F(2, 45) = 4.74, p < 
.01; Figure 36D).  
 
 
 
Figure 36. CCI mice swam with a left sided turn bias in the water maze. (A) CCI mice 
swam with a significant left sided turn bias compared to naïve (p < .01) and craniotomy 
(p < .05) in the spatial 1 water maze. (B) CCI mice also swam with a significant left sided 
turn bias compared to naïve in the spatial 2 water maze (p < .05). (C) CCI mice continued 
to swim with a left sided turn bias compared to naïve in the spatial 3 water maze (p < 
.05). (D) CCI mice swam with a significant left sided bias in all of the probe trials 
compared to naïve (p < .01) and craniotomy (p < .05). 
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Although CCI mice had severe motor deficits, swim speed did not differ in the spatial and 
probe water maze (p > .05; Figure 37). 
 
 
 
Figure 37. Swim speed did not differ in the water maze. (A) Swim speed did not differ 
between groups in the spatial 1 water maze (p > .05). (B) Swim speed did not differ 
between groups in the spatial 2 water maze (p > .05). (C) Swim speed did not differ 
between groups in the spatial 3 water maze (p > .05). (D) Swim speed did not differ 
between groups in the probe trials of the water maze (p > .05).  
 
 
 
 Overall, gender did not affect performance in the spatial water maze (p > .05). 
Male and female mice did not differ in the distance moved (Figure 38), time to find the 
submerged platform (Figure 39), cumulative distance swam (Figure 40), average distance 
to the platform (Figure 41), swim turn bias (Figure 42), and swim speed (Figure 43).  
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Figure 38. Gender did not influence swim distance in the water maze. (A) Male and 
female mice did not differ in the distanced moved in the spatial 1 water maze (p > .05). 
(B) Male and female mice did not differ the distance moved in the spatial 2 water maze 
(p > .05). (C) Male and female mice did not differ in the distance moved in the spatial 3 
water maze (p > .05).  
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Figure 39. Gender did not influence time to the platform in the water maze. (A) Male and 
female mice did not differ in the time it took to find the submerged platform in the spatial 
1 water maze (p > .05). (B) Male and female mice did not differ in the time it took to find 
the submerged platform in the spatial 2 water maze (p > .05). (C) Male and female mice 
did not differ in the amount of time it took to find the submerged platform in the spatial 3 
water maze (p > .05).  
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Figure 40. Gender did not influence the cumulative distance mice swam in the water 
maze. (A) Male and female mice did not differ in the total distance swam in the spatial 1 
water maze (p > .05). (B) Male and female mice did not differ in the total distance swam 
in the spatial 2 water maze (p > .05). (C) Male and female mice did not differ in the total 
distance swam in the spatial 3 water maze (p > .05). (D) Male and female mice did not 
differ in the total distance swam in the probe water maze trials (p > .05).  
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Figure 41. Gender did not influence the average distance to the platform in the water 
maze. (A) Male and female mice did not differ in the average distance swam to the 
platform in the spatial 1 water maze (p > .05). (B) Male and female mice did not differ in 
the average distance swam to the platform in the spatial 2 water maze (p > .05). (C) Male 
and female mice did not differ in the average distance swam to the platform in the spatial 
3 water maze (p > .05). (D) Male and female mice did not differ in the average distance 
swam to the platform in the probe water maze trials (p > .05).  
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Figure 42. Gender did not influence turn bias in the water maze. (A) Male and female 
mice did not differ in swim turn bias in the spatial 1 water maze (p > .05). (B) Male and 
female mice did not differ in swim turn bias in the spatial 2 water maze (p > .05). (C) 
Male and female mice did not differ in swim turn bias in the spatial 3 water maze (p > 
.05). (D) Male and female mice did not differ in swim turn bias in the probe water maze 
trials (p > .05).  
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Figure 43. Gender did not influence swim speed in the water maze. (A) Male and female 
mice did not differ in swim speed in the spatial 1 water maze (p > .05). (B) Male and 
female mice did not differ in swim speed in the spatial 2 water maze (p > .05). (C) Male 
and female mice did not differ in swim speed in the spatial 3 water maze (p > .05). (D) 
Male and female mice did not differ in swim speed in the probe water maze trials (p > 
.05).  
 
 
 
 More detailed analysis of the probe trials revealed injury dependent deficits. CCI 
mice (M = 29.32, SD = 1.87) spent the least time searching for the platform in the area it 
was located the day before (target quadrant) than naïve (M = 22.58, SD = 1.51), F(2, 45) 
= 4.96, p < .01; Figure 44B). Diet (Figure 44A) and gender (Figure 44C) did not affect 
the time they spent searching for the platform in the correct quadrant (p > .05).  
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Figure 44. Injury severity influenced the time mice spent searching for the platform in 
the water maze. (A) The grape-enriched diet did not increase the amount of time mice 
spent searching for the platform in the location it was in the day before in the probe water 
maze trials (p > .05). (B) CCI mice spent the least time searching for the platform in the 
location it was in the day before compared to naïve in the probe water maze trials (p < 
.01). (C) Male and female mice did not differ in the time spent searching for the platform 
in the location it was in the day before in the probe water maze trials (p > .05).  
 
 
 
Overall, there were no differences in the amount of time mice spent searching for the 
platform in the opposite location during the probe water maze trials (Figure 45; p > .05).  
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Figure 45. Mice did not differ in the time spent looking for the platform in the opposite 
location. (A) The grape-enriched diet did not reduce the amount of time mice spent 
looking for the platform in the opposite location (p > .05). (B) Naïve, craniotomy, and 
CCI mice did not differ in the amount of time spent looking for the platform in the 
opposite location (p > .05). (C) Male and female mice did not differ in the amount of time 
spent looking for the platform in the opposite location (p > .05).  
 
 
 
Similar to spatial water maze data, CCI mice (M = 45.83, SD = 1.13) swam longer 
distances searching for the platform in the probe trials than naïve (M = 39.45, SD = 1.35), 
F(2, 45) = 5.04, p < .01; Figure 46B). Diet (Figure 46A) and gender (46C) did not affect 
the total swim distance in the probe water maze trials (p > .05).   
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Figure 46. Injury severity influenced the swim distance mice swam searching for the 
platform in the water maze. (A) The grape-enriched diet did not reduce the distance mice 
swam in search of the platform (p > .05). (B) CCI mice swam a longer distance in search 
of the platform compared to naïve in the probe water maze trials (p < .01). (C) Male and 
female mice did not differ in the total swim distance in the probe water maze trials (p > 
.05).  
 
 
 
 Most interestingly, the grape-enriched diet had a significant positive impact in 
craniotomy mice. Craniotomy mice (M = 9011.33, SD = 749.79) on the enriched diet 
swam shorter distances searching for the platform than control (M = 12927.45, SD = 
1426.49) in the spatial 2 water maze, F(1, 14) = 4.97, p < .05; Figure 47A). Similarly, 
craniotomy mice (M = 40.48, SD = 1.98) on the enriched diet swam a shorter average 
distance to the platform than control (M = 48.18, SD = 1.71) in the spatial 2 water maze, 
F(1, 14) = 8.73, p < .01; Figure 47B). Lastly, male craniotomy mice (M = 37.63, SD = 
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1.11) swam a shorter average distance to the platform than females (M = 41.58, SD = 
1.57) in the spatial 3 water maze, F(1, 46) = 4.20, p < .05; Figure 47C).   
 
 
 
Figure 47. Diet and gender had a significant effect in craniotomy mice. (A) Craniotomy 
mice on the enriched diet swam shorter distances in search of the submerged platform in 
the spatial 2 water maze (p < .05). (B) Craniotomy mice on the enriched diet also swam a 
shorter average to the platform in the spatial 2 water maze (p < .01). (C) Male craniotomy 
mice swam a shorter average distance to the platform in the spatial 3 water maze (p < 
.05).  
 
 
 
 Overall, injury severity did not affect depression-like behaviors (Figure 48).   
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Figure 48. Injury did not influence depressive-like behavior in the tail suspension test (A) 
Naïve, craniotomy, and CCI mice did not differ in the total time spent immobile (p > 
.05). (B) Naïve, craniotomy, and CCI mice did not differ in the time they first became 
immobile during the test (p > .05). (C) Naïve, craniotomy, and CCI mice did not differ in 
the time they spent immobile during the last four minutes of the test (p > .05). (D) Naïve, 
craniotomy, and CCI mice did not differ in the total percentage of time spent immobile (p 
> .05).  
 
 
 
Similarly, differences between male and female mice were not detected in the tail 
suspension test (Figure 49).  
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Figure 49. Gender did not influence depressive-like behavior in the tail suspension test. 
(A) Male and female mice did not differ in the total amount of time spent immobile on 
the test (p > .05). (B) Male and female mice did not differ in the amount of time spent 
immobile during the last 4 minutes of the test (p > .05). (C) Male and female mice did not 
differ in the time they first became immobile in the test (p > .05). 
 
 
 
Aim 3: The Influence of a Grape-Enriched Diet and/or Brain Injury on Alzheimer’s 
Disease Neuropathology 
Influence of Diet on Alzheimer’s Disease Neuropathology 
 The grape-enriched diet did not influence total amyloid (Figure 50A) or fibrillar 
(Figure 50B) plaque burden in the brain.  
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Figure 50. Diet did not affect Alzheimer’s disease pathology. (A) The enriched diet did 
not reduce total plaque burden in the brain (p > .05). (B) The enriched diet did not reduce 
fibrillar plaque burden in t he brain (p > .05). 
 
 
 
Influence of Injury on Alzheimer’s Disease Neuropathology 
 Brain injury did not increase AD neuropathology. In fact, craniotomy mice (M = 
.39, SD = .08) had lower total Aβ in the brain than naïve mice (M = .68, SD = .08) (F(2, 
35) = 3.90, p < .05; Figure 51A). Plaque load did not differ in CCI mice (M = .11, SD = 
.05) compared to naïve and craniotomy mice (p > .05). CCI mice less fibrillar Aβ in the 
brain compared to naïve (M = .23, SD = .03) (F(2, 33) = 3.72, p < .05; Figure 51B).  
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Figure 51. Brain injury influenced AD neuropathology. (A) Craniotomy mice had lower 
Aβ plaque burden in the brain compared to naïve mice (p < .05). (B) CCI mice had lower 
fibrillar Aβ plaque burden in the brain compared to naïve mice (p < .05).   
 
 
Representative pictures of total Aβ plaque and fibrillar Aβ plaque staining in the brain are 
shown in Figures 52 and 53, respectively. 
 
 
 
Figure 52. Representative staining for total Aβ plaque staining in the brain. Bright spots 
are positive staining. (A) Higher amounts of positive staining were found in naïve mice. 
(B) Craniotomy mice had fewer amounts of positive staining. (C) CCI mice had the least 
amount of positive staining in the brain.  
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Figure 53. Representative staining for fibrillar Aβ plaque staining in the brain. Bright 
spots are positive staining. (A) Higher amounts of positive staining were found in naïve 
mice. (B) Craniotomy mice had fewer amounts of positive staining, but did not differ 
from naïve or CCI. (C) CCI mice had the least amount of positive staining.  
 
 
 
Interactions between the Enriched Diet and Injury 
 Brain injured mice on the enriched diet did not have smaller lesions or Aβ 
deposition in the brain (p > .05; Figure 54).  
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Figure 54. Interactions between brain injury and diet were not found. (A) Craniotomy 
mice on the enriched diet had a reduced lesion volume compared to control (p < .05). 
Diet did not affect lesion volume in CCI mice (p > .05). (B) Injured mice on the grape-
enriched diet did not have reduced Aβ deposition in the brain (p > .05). (C) Injured mice 
on the grape-enriched diet did not have reduced fibrillar Aβ deposition in the brain (p > 
.05).    
 
 
 
Aim 4: The Influence of a Grape-Enriched Diet and/or Brain Injury on Blood Brain 
Barrier Clearance and Astrogliosis 
Influence of Diet on BBB Clearance and Astrogliosis 
The grape-enriched diet did not result in a reduction of RAGE (Figure 55A) and 
GFAP expression. In fact, mice on the enriched diet (M = .06, SD = .004) had more 
GFAP expression than control (M = .05, SD = .003) (F(1, 39) = 4.46, p < .05; Figure 
55B).  
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Figure 55. The grape-enriched diet did not reduce RAGE or GFAP expression in the 
brain. (A) Diet did not influence RAGE expression in the brain (p > .05). (B) The grape-
enriched diet led to increased GFAP expression in the brain (p < .05). 
 
 
 
Influence of Injury on BBB Clearance and Astrogliosis 
 Brain injury did not affect RAGE or GFAP expression in the brain (Figure 56).  
 
 
 
Figure 56. Brain injury did not influence BBB clearance or astrogliosis. (A) Brain injury 
did not affect the expression of RAGE in the brain (p > .05). (B) Brain injury did not 
affect the expression of GFAP in the brain (p > .05).  
 
 
Interactions between the Enriched Diet and Injury 
 Brain injured mice on the enriched diet did not have less RAGE and astroglial 
activity (GFAP) in the cortex (p > .05; Figure 57).  
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Figure 57. Interactions between brain injury and diet were not found. (A) Brain injured 
mice on the enriched diet did not have reduced RAGE expression in the cortex (p > .05). 
(B) Brain injured mice on the enriched diet did not have reduced astroglial activity in the 
cortex (p > .05).  
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Correlations 
 
Grape-Enriched Diet 
 Grape-enriched mice had improved in activity, but increased in affective 
behaviors across tests. Specifically, grape-enriched mice that had smaller lesions 
demonstrated better motor skills and coordination, r = -.60, p = .039 (Figure 58). 
Furthermore, grape-enriched mice that had smaller lesions had greater Aβ (r = -.96, p = 
.00; Figure 59) and fibrillar Aβ deposition in the brain (r = -.67, p = .048; Figure 60).  
 
 
 
Figure 58. Grape-enriched mice with smaller lesions took longer to fall off the rotarod, p 
= .039.  
 
 
 
 93 
 
 
Figure 59. Grape-enriched mice with smaller lesions had more Aβ deposition (HJ3.4) in 
the hippocampus, p = .003.   
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Figure 60. Grape-enriched mice with smaller lesions had more fibrillar Aβ deposition 
(ThioS) in the brain, p = .003.   
 
 
 
Grape-enriched mice that displayed less avoidance/anxiety behavior on the zero maze 
(Day 1), took longer to find the platform in the Spatial 1 water maze (r = -.45, p = .029; 
Figure 61). Similarly, grape-enriched mice that displayed less avoidance/anxiety behavior 
on the zero maze (Day 2), took longer to give up (i.e. less depressed) on the tail 
suspension test (r = -.41, p = .046; Figure 62). Interestingly, grape-enriched mice that 
displayed less depressive-like behavior on the tail suspension test had more fibrillar Aβ 
deposition in the cortex (r = -.69, p = .002; Figure 63).  
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Figure 61. Grape-enriched mice that spent less time in the dark in the zero maze took 
longer to find the submerged platform in the Spatial 1 water maze, p = .029.  
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Figure 62. Grape-enriched mice that spent less time in the dark in the zero maze spent 
more time struggling before becoming immobile in the tail suspension test, p = .046.  
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Figure 63. Grape-enriched mice that spent the least time immobile had higher fibrillar Aβ 
deposition in the cortex, p = .002.   
 
 
 
Control Diet 
 Whereas grape supplementation was associated with lesion size, plaque 
deposition, and affective behaviors, the control diet influenced motor skills and 
exploratory patterns in mice. Control mice with larger lesions took longer to find the 
platform in the Spatial 3 water maze (r = .70, p = .008; Figure 64).  
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Figure 64. Control mice with larger lesions spent more time to locate the submerged 
platform in the Spatial 3 water maze, p = .008.  
 
 
 
 Control mice that demonstrated better motor skills/coordination had reduced 
exploratory activity in the open field test (r = .44, p = .039; Figure 65). Surprisingly, mice 
that displayed less depressive-like behavior were also less efficient in the water maze by 
searching for the platform in the opposite quadrant in the Probe trials (r = -.56, p = .007; 
Figure 66).  
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Figure 65. Control mice that performed better on the rotarod also spent more time in the 
corner of the bin (did not explore) in open field testing, p = .039.  
 
 
 100 
 
 
Figure 66. Control mice that spent less time immobile also spent more time searching for 
the platform in the opposite quadrant in the Probe water maze trials, p = .007.  
 
 
 
 In addition, control mice that had reduced exploratory activity in the center of the 
open field test also took longer to locate the platform in the Spatial 1 water maze (r = -
.46, p = .048; Figure 67). Similarly, control mice that did not explore the open field test 
also had increased Aβ deposition in the hippocampus (r = .51, p = .053; Figure 68).  
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Figure 67. Control mice that spent less time exploring in the open field test also took 
longer to find the submerged platform in the Spatial 1 water maze, p = .029.  
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Figure 68. Control mice that spent more time in the perimeter of the open field test also 
had more Aβ deposition in the hippocampus, p = .053.  
 
 
 
Controlled Cortical Impacted Mice 
CCI mice were hyperactive and water maze performance was influenced by 
RAGE and reactive astrogliosis. For example, larger lesions were associated with 
hyperactive exploratory behaviors (increase in distance traveled; r = .68, p = .03; Figure 
69). Hyperactive behaviors led to better search strategies in the Probe water maze trials, 
with CCI mice spending more time in the correct quadrant searching for the platform (r = 
.73, p = .01; Figure 70). Interestingly, slower exploration/activity was related to higher 
levels of RAGE in the cortex (r = -.66, p = .04; Figure 71) in CCI mice.  
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Figure 69. CCI that had larger lesions traveled farther in open field test, p = .03).  
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Figure 70. The faster CCI mice explored in open field test, the more time they spent 
searching for the submerged platform in the correct quadrant in Probe water maze trials, 
p = .01.  
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Figure 71. The slower CCI mice explored in the open field test, the more RAGE staining 
they had in the cortex, p = .04.  
 
 
 
 CCI mice that had more astrogliosis did not display depressive-like behaviors 
(longer to become immobile in the tail suspension test; r = .61, p = .049; Figure 72), 
suggesting that these mice may have had activated repair mechanisms to reduce apoptosis 
in the cortex. Similarly, CCI mice with reduced RAGE expression performed better in the 
Probe water maze trials (r = -.80, p = .006; Figure 73), by spending more time searching 
for the platform in the correct quadrant. Lastly, increased RAGE expression led to more 
fibrillar Aβ deposition in the cortex (r = .80, p = .029; Figure 74) 
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Figure 72. CCI mice that had more astrogliosis in the cortex also took longer to become 
immobile in the tail suspension test, p = .049.  
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Figure 73. CCI that had reduced RAGE expression in the cortex spent more time 
searching for the platform in the correct quadrant in Probe water maze trials, p = .006. 
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Figure 74. CCI mice that had increased RAGE expression in the cortex also had 
increased fibrillar Aβ deposition in the brain, p = .029.  
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CHAPTER FOUR 
DISCUSSION 
 Animal models have essential to understanding the behavioral and biological 
consequences of AD. These models have shown the development and progression of the 
disease similar to those reported in clinical populations. The purpose of this study was to 
explore the effects of TBI on behavior and plaque burden in a mouse model of AD, as 
well as the protective effects of a grape-enriched diet in AD and TBI. We found the 
grape-enriched diet to be more protective in mice with mild brain injury (craniotomy) 
than those with moderate to severe brain injury. Our findings also show that brain injury 
may have protected against Aβ pathology in the brain.   
 
Effects of Diet, Injury, and Gender on Behavior 
 CCI is a model commonly used to model the pathological and behavioral features 
of moderate to severe injury in the human TBI population. We have shown that mild CCI 
in rodents causes extensive white matter tissue disruption (Donovan et al., 2012; 
Donovan et al., 2014) and moderate CCI leads to motor and behavioral impairments 
(Ajao et al., 2012; Brody et al., 2007; Kamper et al., 2013), confirming our current 
findings. The moderate nature of the injury produced more tissue damage and motor 
deficits than the craniotomy mice. General exploratory activity levels are also altered in 
CCI mice and rats, with increased anxious activities and less likely to engage in 
exploratory behavior, though hyperactivity has also been reported. Similar to our 
correlative results, TBI rodents have been reported to display hyperactivity in open field 
testing (Hsieh et al., 2014; Li et al., 2006). In addition, several studies have reported 
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behavioral impairments are present immediately following TBI (Ajao et al., 2012; 
Hartman et al., 2012; Kamper et al., 2013, confirming our results in the rotarod and 
performance in the standard water maze and relative angular velocity (turn bias). CCI 
mice had impaired performance in the water maze, taking longer to learn the location of 
the platform each day. These mice also showed significant impairment in the probe trials.   
Surprisingly, mild-injured craniotomy mice also displayed motor deficits on the rotarod 
and learning deficits during the cued learning trials of the water maze, though other 
studies have reported impairments found in larger mild injuries (Donovan et al., 2012, 
Donovan et al., 2014; Washington et al., 2012). 
 Many studies have shown polyphenols to be neuroprotective and supplementation 
reduces inflammation (Ates et al., 2007; Gomez-Serranillos et al., 2009; Loren et al., 
2005; Wang et al., 2009) and AD neuropathology (Hartman et al., 2006; Wang et al., 
2006; Ho et al., 2009). Our study reports that the grape-enriched diet produced smaller 
brain lesions, fewer sensorimotor deficits in craniotomy mice, though results did not 
reach statistical significance. Perhaps most surprising, the grape-enriched diet was found 
to be the most influential in mild injured craniotomy mice only compared to CCI. 
Interestingly, the craniotomy surgery seemed to produce brain damage that mimicked 
mild brain injury and its corresponding behavioral deficits. These results indicate that the 
grape diet may have a small, but positive effect on motor activity in mild brain injury. 
Interestingly, the polyphenol diet significantly influenced learning and memory in 
craniotomy mice, consistent with several studies (Dulcich et al., 2013; Hartman et al., 
2006)f. In addition grape-enriched craniotomy male mice found the location of the 
platform faster than females. Females did not dominate performance over males 
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previously published (Dulcich et al., 2013), though the injury mechanism and polyphenol 
supplementation were different.   
Some studies report that polyphenols produce antidepressant-like activity similar 
to the effects of pharmaceuticals (Liu et al., 2013; Wang et al., 2013; Zhu et al., 2012). In 
contrast, our study found that the grape-enriched diet resulted in more depressive-type of 
behaviors in CCI mice compared to controls. Our findings may be attributed to the 
specific interactions between grape polyphenols, TBI and AD neuropathology. The AD 
neuropathology in these mice may mask polyphenolic properties that have shown 
positive results in other studies. Further studies should investigate the mechanistic 
pathways polyphenols affect the brain.  
 
Effects of Diet and Injury on AD neuropathology and the BBB 
 Polyphenol supplementation has also been shown to reduce AD neuropathology 
(Hartman et al. 2006; Ho et al., 2009; Joseph et al., 2003; Wang et al., 2006). Many 
studies have reported that TBI exacerbates AD neuropathology exponentially (Gentleman 
et al., 1997; Roberts et al., 1994; Uryu et al., 2002; Valle et al., 2001), however, we found 
that brain injury did not up-regulate A mediating BBB proteins. In fact, we report that 
TBI, not the grape-enriched diet, significantly reduced AD neuropathology. Because the 
grape diet was started at around the age when Aβ plaques are just beginning to appear in 
PSAPP mice and may have influenced the time course of Aβ aggregation and 
accumulation in the brain. Naïve mice had more A and fibrillar A compared to 
craniotomy and CCI mice, respectively. Although this finding is controversial, some 
studies have found that TBI reduces AD plaque burden in the brain. A plaques have 
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been found shortly after TBI in adults, however few plaques were found several months 
to years despite accumulation of A in the axons (Chen, Johnson, Uryu, Trojanowski & 
Smith 2008). Hippocampal plaque burden is also found to regress in the ipsilateral 
hippocampus several weeks post-TBI, compared to the contralateral hippocampus 
(Nakagawa et al., 2000). In fact, the loss of ipsilateral hippocampal CA3 neurons by CCI 
may be responsible for the short-term increase in A levels (Smith et al., 1998), whereas 
the over expression of Bcl-2 (B-Cell CLL/Lymphoma 2) post-injury may be responsible 
for the long-term neuroprotection (Nakamura et al., 1999). The Bcl-2 gene is known to 
inhibit both apoptosis and necrosis cell death initiated by brain injury. Alternatively, the 
acute increase in A caused by the initial injury may not compromise neurons enough to 
engage in long-term amyloid accumulation. Additional injuries may be necessary for 
neurons to become more susceptible and process higher concentrations of A, leading to 
more degeneration over time (Nakagawa et al., 1999). 
Grapes have also been found to protect against oxidative damage and promote 
astrogliosis. Cell culture treated with GSE increased hippocampal astrocyte activity 
against oxidative stress (Fujishita et al., 2009). Increased astrocyte activity was also 
found in cells that were pre-treated with wine (Gomez-Serranillos et al., 2009). This is 
similar to what we demonstrated in this study. We found that grape-enriched mice had 
increased astroglial activity in the cortex, suggesting the significant role polyphenols play 
in mediating oxidative activity.  
 
Future Directions 
 Determining the mechanisms that TBI reduces A pathogenesis is beyond the 
 113 
scope of the current study. Future projects should focus on determining the levels of 
oxidative stress, apoptosis, or Bc1-2 to better understand the attenuation mechanisms of 
TBI in AD. Also, biochemistry (Elisa kits) of fresh frozen tissue would confirm whether 
the controversial findings from this study are indeed true. Further, swim strategy analysis 
may also provide a more sensitive detection of whether grape-enriched mice used 
different search techniques to find the platform.  
 
Conclusions 
 Our findings suggest that TBI reduced the production of A. Instead behavioral 
deficits may have been a result of injury severity, rather than AD pathology. Injury 
induced motor and behavioral deficits were prominent, consistent to literature. 
Surprisingly, the grape-enriched diet was far more protective in a mild brain injury and 
more detrimental in moderate injury.  
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